Resistenzen bei tierpathogenen Bakterien – ein Update · Symposium Antibiotikaresistenz in der LM...
Transcript of Resistenzen bei tierpathogenen Bakterien – ein Update · Symposium Antibiotikaresistenz in der LM...
-
Resistenzen bei tierpathogenen Bakterien – ein Update
-
Seite 2
Die Welt der übertragbaren Resistenzen
Symposium Antibiotikaresistenz in der LM-Kette, Heike Kaspar
-
Seite 3
Makrolide Penicilline
Polypeptide Fluorchinolone Cephalosporine Aminoglykoside
Diaminopyrimidine Pleuromutiline Lincosamide Sulfonamide Tetrazykline
Fenicole
Carbapeneme Glycopeptide Glycylcycline Monobactame Streptogramine Quinoxaline Ansamycine Zyklische- Lipopeptide Oxazolidinone Ketolide
Veterinärmedizin Humanmedizin
Zugelassene Wirkstoffklassen
Symposium Antibiotikaresistenz in der LM-Kette, Heike Kaspar
-
Seite 4 Symposium Antibiotikaresistenz in der LM-Kette, Heike Kaspar
Nationales Resistenzmonitoring bei tierpathogenen Erregern in Deutschland Zielstellung Datenbasis für die Abschätzung von Risiken und Ableitung von Managementmaßnahmen Einschätzung des Risikos, das aus dem Tierbereich auf den Menschen einwirken kann Früherkennung von Resistenz (u. a. „empirische“ Therapie) Trends der Resistenzentwicklung erfassen Epidemiologische Zusammenhänge aufklären
-
Seite 5 Symposium Antibiotikaresistenz in der LM-Kette, Heike Kaspar
Nationales Resistenzmonitoring bei tierpathogenen Erregern in Deutschland Hintergrund • Resistenzen haben einen „One Health“ Bezug, dies gilt für den
Menschen, das Tier und die Umwelt • Resistenzmonitoring auf Basis §77 Abs. 3, AMG regelmäßige Berichtspflicht des BVL zu Resistenzdaten von klinischen
Isolaten • BVL entwickelt jährlich einen dezidierten Stichprobenplan unter Berücksichtigung von aktuellen Entwicklungen • Isolateinsendung von Laboren an BVL zur Resistenzbestimmung
-
Seite 6 Symposium Antibiotikaresistenz in der LM-Kette, Heike Kaspar
Konzeption Resistenzmonitoring
Antibiotikaresistenzmonitoring GERM Vet
nationales Resistenzmonitoring veterinärpathogener Bakterien seit 2001
ca. 3500 – 4000 Isolate pro Jahr
klinisch erkrankte Tiere
Lebensmittel liefernde Tiere
nicht-Lebensmittel liefernde Tiere (Hobbytiere)
unauffällige Tiere
Lebensmittel tierischer Herkunft
-
Seite 7
Stichprobenplan (LM liefernde Tiere)
Tierart Indikation Organ Bakterienspzies
Milchrind Mastitis Milch, Euter
Klebsiella spp. Streptococcus spp. Enterococcus spp. E. coli
Kalb, Rind Erkrankungen des Respirationstraktes Bronchien, Lunge Mannheimia spp. Pasteurella multocida
Schwein Enteritis Darm, Kot E. coli
Schwein Hautinfektionen Haut S. aureus S. hyicus
Sammelzeitraum 25.4.2018 – 31.03.2019
Symposium Antibiotikaresistenz in der LM-Kette, Heike Kaspar
-
Seite 8 Symposium Antibiotikaresistenz in der LM-Kette, Heike Kaspar Seite 8
Quantitative Methode: Bouillon-Mikrodilution
Ampicillin Cephalothin CHL Enrofloxacin Penicillin G Tetracyclin Vancomycin SXT
Wirkstoff [mg/L] MHK
+ +
Bewertung der Ergebnisse
• klinische Grenzwerte gemäß CLSI (VET01 5th. ed, VET08)
• veterinärspezifische GW Adaption humanspezifischer GW
• wenn keine GW verfügbar: Beurteilung des MHK90- Wertes
• Angaben zu Resistenzraten nur bei vorhandenen Grenzwerten
-
Seite 9 Symposium Antibiotikaresistenz in der LM-Kette, Heike Kaspar
Bewertungskriterien
Begriffsbestimmung – Nomenklatur Klinische Grenzwerte Sensibel
Intermediär bezogen auf die Wahrscheinlichkeit des
Resistent Therapie erfolges
Epidemiologische Cut-off-Werte
Wildtyp im Bereich der Normalverteilung
Nicht-Wildtyp außerhalb der Normalverteilung
Hinweis auf erworbene Resistenz
-
Seite 10 Symposium Antibiotikaresistenz in der LM-Kette, Heike Kaspar Seite 10
Grenzwert
0
10
20
30
40
50
60
0,06 0,12 0,25 0,5 1 2 4 8 16 32 64Tetracyclin, MHK [mg/L]
M. haemolytica (n = 131), Rind
Klinischer breakpoint ≥ 16 (CLSI)
Epidemiolog. Cut-off ≥ 4
Auswertung der Ergebnisse
-
Seite 11 Symposium Antibiotikaresistenz in der LM-Kette, Heike Kaspar Seite 11
Ergebnisse des Nationalen Resistenzmonitoring
Respiratorische Erkrankungen
-
Seite 12 Symposium Antibiotikaresistenz in der LM-Kette, Heike Kaspar Seite 12
APP, Schwein, Indikation: respiratorische Erkrankungen 2008 - 2014
AMP Ampicillin, CEF Cephalothin, XNL Ceftiofur, ENR Enrofloxacin, FFN Florfenicol, TET Tetracyclin, TIA Tiamulin, TIL Tilmicosin
Ergebnisse
-
Seite 13 Symposium Antibiotikaresistenz in der LM-Kette, Heike Kaspar Seite 13
APP, Schwein, Indikation: respiratorische Erkrankungen MHK90-Daten 2008 - 2014
Ergebnisse
MHK90 [mg/L]
Studienjahr
Wirkstoffe, für die keine klinischen Grenzwerte vorhanden sind
2008 2009 2010 2011 2012 2013 2014
Cefotaxim 0,015 0,015 0,015 0,25 0,015 0,015 0,015 Cefquinom 0,03 0,03 0,03 0,5 0,03 0,03 0,03 Doxycyclin 1 2 2 8 2 2 1 Gentamicin 16 16 8 8 16 16 16 Nalidixinsäure 4 4 4 4 4 4 4 SXT 0,12 0,25 0,12 0,12 0,12 0,12 0,25 Tulathromycin 32 32 16 16 - 32 32 N = 63 40 58 46 41 102 101
-
Seite 14 Symposium Antibiotikaresistenz in der LM-Kette, Heike Kaspar Seite 14
P. multocida, Rind, Indikation: respiratorische Erkrankungen; 2008 - 2017
Ergebnisse
Diagramm1
CeftiofurCeftiofurCeftiofurCeftiofurCeftiofurCeftiofurCeftiofurCeftiofurCeftiofur
EnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacin
FlorfenicolFlorfenicolFlorfenicolFlorfenicolFlorfenicolFlorfenicolFlorfenicolFlorfenicolFlorfenicol
PenicillinPenicillinPenicillinPenicillinPenicillinPenicillinPenicillinPenicillinPenicillin
TulathromycinTulathromycinTulathromycinTulathromycinTulathromycinTulathromycinTulathromycinTulathromycinTulathromycin
TetracyclinTetracyclinTetracyclinTetracyclinTetracyclinTetracyclinTetracyclinTetracyclinTetracyclin
2008 N=75
2009 N=68
2010 N=25
2011 N=72
2012 N=77
2013 N=48
2014 N=75
2016 N=99
2017 N=64
resistente Stämme [%]
1
0
0
0
0
0
0
0
0
1
0
4
0
0
0
1.3
0
1.6
1
0
0
1.4
1.3
0
0
3
1.6
1.3
3.2
0
5.6
1.3
2.1
0
2
3.1
0
0
0
0
0
0
3
12.7
7
13
4
12.5
5.2
10.4
6.7
15
30.2
Rind
PasteurellaRindalle Produktionsstufen
2008 N=752009 N=682010 N=252011 N=722012 N=772013 N=482014 N=752016 N=992017 N=64
Ceftiofur100000000
Enrofloxacin1040001.301.6
Florfenicol1001.41.30031.6
Penicillin1.33.205.61.32.1023.1
Tulathromycin000000312.7
Tetracyclin713412.55.210.46.71530.2
n=756825727748759964603
Wirkstoffe, für die keine klinischen Grenzwerte vorhanden sindMHK90 [mg/L]
Studienjahr200820092010201120122013201420162017
Ampicillin0.250.50.510.250.250.50.250.5
Cefoperazon0.060.0610.060.0150.060.060.060.06
Cefotaxim0.0150.0150.030.0150.0150.0150.0150.0150.015
Cefquinom0.060.060.060.060.0150.060.060.060.06
Colistin444424284
Doxycyclin12110.51111
Marbofloxacinn.g.n.g.n.g.n.g.0.060.120.060.060.06
Nalidixinsäure42244128222
Neomycinn.g.n.g.n.g.n.g.n.g.163216>64
Streptomycinn.g.n.g.n.g.n.g.n.g.>51264>512>512
Tilmicosin888881688128
Trimethoprim/Sulfamethoxazol0.50.250.250.250.252160.251
Anzahl Isolate (N)756821727748759964
2008 N=752009 N=682010 N=212011 N=722012 N=772013 N=482014 N=752016 N=992017 N=64
Ampicillin0.250.50.510.250.250.50.250.5
Cefotaxim0.0150.0150.030.0150.0150.0150.0150.0150.015
Doxycyclin12110.51111
Marbofloxacinn.g.n.g.n.g.n.g.0.060.120.060.060.06
Nalidixinsäure42244128222
Tilmicosin888881688128
Trim/Sulf0.50.250.250.250.252160.251
756821727748759964
Rind
2008 N=75
2009 N=68
2010 N=25
2011 N=72
2012 N=77
2013 N=48
2014 N=75
2016 N=99
2017 N=64
resistente Stämme [%]
Katze
2008 N=75
2009 N=68
2010 N=21
2011 N=72
2012 N=77
2013 N=48
2014 N=75
2016 N=99
2017 N=64
log2 MHK90-Wert
Wirkstoffe, für die keine klinischen Grenzwerte vorhanden sindMHK90 [mg/L]
Studienjahr2010201120122013/201420152016
Ampicillin0.50.510.250.250.25
Amoxicillin/Clavulansäure0.50.50.50.50.50.5
Cefoperazon0.060.060.120.060.060.06
Cefotaxim0.0150.0150.030.0150.0150.015
Cefquinom0.060.060.120.060.0150.06
Ceftiofur0.030.0150.060.060.030.06
Doxycyclin0.50.50.250.250.250.25
Enrofloxacin0.030.030.030.030.030.03
Gentamicin444444
Marbofloxacinn.g.n.g.0.030.060.030.03
Nalidixinsäure224122
Penicillin0.250.250.250.250.250.25
Tetracyclin10.510.50.50.5
Trimethoprim/Sulfamethoxazol0.120.120.12320.060.12
Anzahl Isolate (N)6410918232019
-
Seite 15 Symposium Antibiotikaresistenz in der LM-Kette, Heike Kaspar
0
5
10
15
20
25re
sist
ente
Stä
mm
e [ %
]
2008 N=217 2009 N=154 2010 N=73 2013 N=151 2015 N=145
P. multocida, Schwein, Indikation: respiratorische Erkrankungen; 2008 - 2015
Diagramm1
AmpicillinAmpicillinAmpicillinAmpicillinAmpicillin
CeftiofurCeftiofurCeftiofurCeftiofurCeftiofur
EnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacin
FlorfenicolFlorfenicolFlorfenicolFlorfenicolFlorfenicol
PenicillinPenicillinPenicillinPenicillinPenicillin
TetracyclinTetracyclinTetracyclinTetracyclinTetracyclin
TilmicosinTilmicosinTilmicosinTilmicosinTilmicosin
TulathromycinTulathromycinTulathromycinTulathromycinTulathromycin
2008 N=217
2009 N=154
2010 N=73
2013 N=151
2015 N=145
resistente Stämme [ %]
6.5
5.8
4.1
4
1.4
0
0
2.7
0
0
0.9
0
0
0.7
0.7
0
0.6
1.4
0.7
0
6.9
5.8
8.2
4
1.4
21.7
18.2
17.8
8.7
8.3
0.9
0
4.1
0
0.7
0.5
0
2.7
0
0.7
Pasteurella Schwein
2008 N=2172009 N=1542010 N=732013 N=1512015 N=145Pasteurella Schwein
Ampicillin6.55.84.141.4
Ceftiofur002.700
Enrofloxacin0.9000.70.7
Florfenicol00.61.40.70
Penicillin6.95.88.241.4
Tetracyclin21.718.217.88.78.3
Tilmicosin0.904.100.7
Tulathromycin0.502.700.7
n21715473151145
Pasteurella Schwein
2008 N=217
2009 N=154
2010 N=73
2013 N=151
2015 N=145
resistente Stämme [ %]
Tabelle1
-
Seite 16 Symposium Antibiotikaresistenz in der LM-Kette, Heike Kaspar Seite 16
Ergebnisse des Nationalen Resistenzmonitoring
Enteritis
-
Seite 17 Symposium Antibiotikaresistenz in der LM-Kette, Heike Kaspar Seite 17
E. coli, Ferkel, Indikation: Enteritis; 2006 - 2017
Ergebnisse
0
10
20
30
40
50
60
70
80
90
100
Ampicillin Amox/Clav Chloramphenicol Gentamicin Tetrazyklin Trimeth/Sulfa
[%] r
esis
tent
e St
ämm
e
2006/2007 N=345 2008 N=240 2009 N=124 2010 N=156 2011 N=183
2012 N=150 2015 N=134 2016 N=133 2017 N=118
Chloramphenicol nur bis 2012 untersucht
Diagramm1
AmpicillinAmpicillinAmpicillinAmpicillinAmpicillinAmpicillinAmpicillinAmpicillinAmpicillin
Amox/ClavAmox/ClavAmox/ClavAmox/ClavAmox/ClavAmox/ClavAmox/ClavAmox/ClavAmox/Clav
ChloramphenicolChloramphenicolChloramphenicolChloramphenicolChloramphenicolChloramphenicolChloramphenicolChloramphenicolChloramphenicol
GentamicinGentamicinGentamicinGentamicinGentamicinGentamicinGentamicinGentamicinGentamicin
TetrazyklinTetrazyklinTetrazyklinTetrazyklinTetrazyklinTetrazyklinTetrazyklinTetrazyklinTetrazyklin
Trimeth/SulfaTrimeth/SulfaTrimeth/SulfaTrimeth/SulfaTrimeth/SulfaTrimeth/SulfaTrimeth/SulfaTrimeth/SulfaTrimeth/Sulfa
2006/2007 N=345
2008 N=240
2009 N=124
2010 N=156
2011 N=183
2012 N=150
2015 N=134
2016 N=133
2017 N=118
[%] resistente Stämme
62
67
69
71.4
75.4
74
57.5
62.4
62.7
3
2
2
11.3
2.2
1.3
3
0
3.4
31
26
27
24.2
32.8
22.7
10
6
11
13
10.9
11.3
2.2
6.8
7.7
80
73
77
78.9
79.2
72.7
59.7
62.4
55.6
50
50
61
55.9
59
56
43.3
51.1
45.3
Kalb
E. coli Kalb
2006/2007 N=1542008 N=1662009 N=1602010 N=1432011 N=1612012 N=2872013 N=2502014 N=2842015 N=1692016 N=1142017 N=114
Ampicillin687076.376.979.776.377.671.568.666.775.4
Amox/Clav18161519.617.41518.821.52610.516.7
Cephalothin443741.348.342.446.439.4424349.1
Chloramph495150.659.455.548.1
Gentamicin2321253539.928.640.437.722.519.324.6
Tetrazyklin717168.169.275.770.474.463.759.86465.8
Trimeth/Sulfa445148.152.449.457.855.647.242.639.544.7
Summe
n=1541661601431732872502841691141142014
2006/2007 N=1542008 N=1662009 N=1602010 N=1432011 N=1612012 N=2872013 N=2502014 N=2842015 N=1692016 N=1142017 N=114
Imipenemn.g.n.g.n.g.n.g.n.g.0.250.250.250.250.250.25
Colistin0.50.50.5121120.50.50.5
Nalidixinsäure256256256256256256256256256256256
Ciprofloxacinn.g.n.g.n.g.n.g.n.g.323232323232
Enrofloxacin3232323232323232323232
Cefotaxim116326464646464646464
Ceftiofur264128128128128128128128128128
Kalb
2006/2007 N=154
2008 N=166
2009 N=160
2010 N=143
2011 N=161
2012 N=287
2013 N=250
resistente Stämme [%]Achsentitel
ESBL
2006/2007 N=154
2008 N=166
2009 N=160
2010 N=143
2011 N=161
2012 N=287
2013 N=250
2014 N=284
2015 N=169
2016 N=114
2017 N=114
[%] resistente Stämme
Tabelle2
2006/2007 N=154
2008 N=166
2009 N=160
2010 N=143
2011 N=161
2012 N=287
2013 N=250
2014 N=284
2015 N=169
2016 N=114
2017 N=114
log2 MHK90-Wert
Ferkel
ESBL Kalb
JahrKalbSchweinGeflügel
2006/200772.30.2
20081141.4
2009193.81.8
2010183.91.4
201125.410.63.6
2012207.92.3
201329.20.6
2014340.6
201526.75.51
201629.83.73.6
Ferkel
2006/2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
Prävalenz ESBL bildender E. coli [%]
Pute
Masthahn
E. coliFerkel
2006/2007 N=3452008 N=2402009 N=1242010 N=1562011 N=1832012 N=1502015 N=1342016 N=1332017 N=118
Ampicillin62676971.475.47457.562.462.7
Amox/Clav32211.32.21.3303.4
Chloramphenicol31262724.232.822.7
Gentamicin106111310.911.32.26.87.7
Tetrazyklin80737778.979.272.759.762.455.6
Trimeth/Sulfa50506155.9595643.351.145.3
Summe
n=3452401241561831501341331181583
2006/2007 N=3452008 N=2402009 N=1242010 N=1562011 N=1832012 N=1502015 N=1342016 N=1332017 N=118
Imipenemn.g.n.g.n.g.n.g.n.g.0.250.250.250.25
Colistin40.5488880.54
Nalidixinsäure128256256128128256256128128
Ciprofloxacinn.g.n.g.n.g.n.g.n.g.40.50.50.5
Enrofloxacin0.5110.50.58211
Cefotaxim0.120.120.120.120.120.50.120.120.12
Ceftiofur0.50.50.50.50.5110.50.5
Masthahn
2006/2007 N=345
2008 N=240
2009 N=124
2010 N=156
2011 N=183
2012 N=150
2015 N=134
2016 N=133
2017 N=118
[%] resistente Stämme
Colistin
2006/2007 N=345
2008 N=240
2009 N=124
2010 N=156
2011 N=183
2012 N=150
2015 N=134
2016 N=133
2017 N=118
log2 MHK90-Wert
E. coli PutePutealle Indikationen
2006/2007 N=1662006/2007 N=1662008 N=1332009 N=852010 N=952011 N=1252012 N=1592013 N=1092014 N=1102015 N=1142016 N=962017 N=64
Ampicillin61.961.965.473.542.159.749.7334033.343.845.3
Amoxi/Clav2.42.41.55.31.151.30.91.82.63.10
Cephalothin42.842.836.833.422.1208.314.513.215.626.6
Chloramph14.914.921.126.621.125.818.922
Enrofloxacin334.504.21.51.35.56.46.15.26.3
Gentamicin1.81.82.32.311.613.68.803.72.66.39.4
Tetrazyklin70.270.262.452.836.84827.716.537.315.82523.4
Trimet/Sulfa35.735.721.821.521.122.425.88.330713.510.9
n=166166133859512515910911011496641422
2006/2007 N=1662008 N=1332009 N=852010 N=952011 N=1252012 N=1592013 N=1092014 N=1102015 N=1142016 N=962017 N=64
Imipenemn.g.n.g.n.g.n.g.0.250.250.250.250.250.250.25
Colistin0.50.580.588120.50.50.5
Nalidixinsäure256128128256256256128256128256128
Ciprofloxacinn.g.n.g.n.g.n.g.0.250.50.50.50.50.50.5
Cefotaxim0.120.120.120.120.120.120.120.120.120.120.12
Ceftiofur0.50.50.50.50.50.50.50.50.50.50.5
2006/2007 N=166
2006/2007 N=166
2008 N=133
2009 N=85
2010 N=95
2011 N=125
2012 N=159
2013 N=109
2014 N=110
2015 N=114
2016 N=96
2017 N=64
[%] resistente Stämme
2006/2007 N=166
2008 N=133
2009 N=85
2010 N=95
2011 N=125
2012 N=159
2013 N=109
2014 N=110
2015 N=114
2016 N=96
2017 N=64
log2 MHK90-Wert
E. coliMasthahn
2006/2007 N=302008 N=212009 N=292010 N=422011 N=742012 N=352013 N=382014 N=312015 N=1092016 N=772017 N=45
Ampicillin6343525035.642.935.838.73335.144.4
Amoxi/Clav1710311.91.411.4001.86.52.2
Cephalothin37242723.825.915.86.56.415.615.6
Chloramph10537.16.88.617.6
Enrofloxacin3539.59.65.75.39.76.42.62.2
Gentamicin3004.89.614.37.93.23.77.82.2
Tetrazyklin40242133.335.634.323.735.516.518.226.7
Trimet/Sulfa4314301916.414.318.425.823.916.920
n=30212942743538311097745531
2006/2007 N=302008 N=212009 N=292010 N=422011 N=742012 N=352013 N=382014 N=312015 N=1092016 N=772017 N=45
Ceftiofur10.50.540.5160.50.50.50.50.5
Cefotaxim0.50.120.1240.12160.120.120.120.250.12
Nalidixinsäure256256256256256256256256256128256
Ciprofloxacinn.g.n.g.n.g.n.g.n.g.0.50.540.50.50.5
Colistin0.50.50.5111110.50.50.5
0.0150.030.060.120.250.51248163264
log2
-6-5-4-3-2-10123456
2006/2007 N=302008 N=212009 N=292010 N=422011 N=742012 N=352013 N=382014 N=312015 N=109
Ceftiofur0-1-12-14-1-1-1
Cefotaxim-1-3-32-34-3-3-3
Nalidixinsäure888888888
Ciprofloxacinn.g.n.g.n.g.n.g.n.g.-1-12-1
Colistin-1-1-100000-1
2006/2007 N=30
2008 N=21
2009 N=29
2010 N=42
2011 N=74
2012 N=35
2013 N=38
2014 N=31
2015 N=109
2016 N=77
2017 N=45
[%] resistente Stämme
2006/2007 N=30
2008 N=21
2009 N=29
2010 N=42
2011 N=74
2012 N=35
2013 N=38
2014 N=31
2015 N=109
2016 N=77
2017 N=45
log2 MHK90-Wert
Tab. 1.6. Anteil mcr-1 positiver Isolate an Colistin-resistenten (E. coli)
SchweinRindGeflügelOthers
2004/050%0%0%0%
2005/060%0%0%0%
2006/076%25%33%0%
20085%0%64%0%
200927%0%92%0%
201047%45%77%0%
201149%0%85%0%
201244%0%95%100%
2013*62%25%0%
2014*45%57%0%
201554%0%50%0%
Table 1.4. Anteil Colistin-resistenter Isolate am Probeneingang
SchweinRindGeflügelOthers
2004/055.1%0.7%0.5%0.0%
2005/063.5%1.1%0.4%0.0%
2006/079.7%2.2%2.7%3.6%
20085.7%4.5%3.3%4.5%
20099.4%3.4%5.5%0.0%
201012.4%2.2%4.5%0.8%
201117.8%1.5%5.3%1.7%
201215.8%0.7%5.2%0.0%
2013*4.9%1.1%0.0%
2014*2.1%2.1%1.1%
201512.3%3.4%0.5%1.0%
Table 1.5. Anteil mcr-1 positiver Isolate am Probeneingang (E. coli)
SchweinRindGeflügelOthers
2004/050.0%0.0%0.0%0.0%
2005/060.0%0.0%0.0%0.0%
2006/070.6%0.5%0.9%0.0%
20080.3%0.0%2.1%0.0%
20092.6%0.0%5.1%0.0%
20105.8%1.0%3.4%0.0%
20118.7%0.0%4.5%0.0%
20126.9%0.0%5.0%1.7%
2013*3.0%0.3%0.0%
2014*0.9%1.2%0.0%
20156.6%0.0%0.3%0.0%
Schwein
Rind
Geflügel
Schwein
Rind
Geflügel
Schwein
Rind
Geflügel
-
Seite 18 Symposium Antibiotikaresistenz in der LM-Kette, Heike Kaspar Seite 18
E. coli, MHK90-Daten, Ferkel, Indikation: Enteritis; 2006 - 2017
Ergebnisse
Ciprofloxacin ab 2012 untersucht
Diagramm1
ColistinColistinColistinColistinColistinColistinColistinColistin
NalidixinsäureNalidixinsäureNalidixinsäureNalidixinsäureNalidixinsäureNalidixinsäureNalidixinsäureNalidixinsäure
CiprofloxacinCiprofloxacinCiprofloxacinCiprofloxacinCiprofloxacinCiprofloxacinCiprofloxacinCiprofloxacin
EnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacin
CefotaximCefotaximCefotaximCefotaximCefotaximCefotaximCefotaximCefotaxim
CeftiofurCeftiofurCeftiofurCeftiofurCeftiofurCeftiofurCeftiofurCeftiofur
2006/2007 N=345
2008 N=240
2009 N=124
2010 N=156
2011 N=183
2012 N=150
2015 N=134
2016 N=133
log2 MHK90-Wert
4
0.5
4
8
8
8
8
0.5
128
256
256
128
128
256
256
128
0
0
0
0
0
4
0.5
0.5
0.5
1
1
0.5
0.5
8
2
1
0.12
0.12
0.12
0.12
0.12
0.5
0.12
0.12
0.5
0.5
0.5
0.5
0.5
1
1
0.5
Kalb
E. coli Kalb
2006/2007 N=1542008 N=1662009 N=1602010 N=1432011 N=1612012 N=2872013 N=2502014 N=2842015 N=1692016 N=114
Ampicillin687076.376.979.776.377.671.568.666.7
Amox/Clav18161519.617.41518.821.52610.5
Cephalothin443741.348.342.446.439.44243
Chloramph495150.659.455.548.1
Gentamicin2321253539.928.640.437.722.519.3
Tetrazyklin717168.169.275.770.474.463.759.864
Trimeth/Sulfa445148.152.449.457.855.647.242.639.5
Summe
n=1541661601431732872502841691141900
2006/2007 N=1542008 N=1662009 N=1602010 N=1432011 N=1612012 N=2872013 N=2502014 N=2842015 N=1692016 N=114
Imipenemn.g.n.g.n.g.n.g.n.g.0.250.250.250.250.25
Colistin0.50.50.5121120.50.5
Nalidixinsäure256256256256256256256256256256
Ciprofloxacinn.g.n.g.n.g.n.g.n.g.3232323232
Enrofloxacin32323232323232323232
Cefotaxim1163264646464646464
Ceftiofur264128128128128128128128128
Kalb
2006/2007 N=154
2008 N=166
2009 N=160
2010 N=143
2011 N=161
2012 N=287
2013 N=250
resistente Stämme [%]Achsentitel
ESBL
2006/2007 N=154
2008 N=166
2009 N=160
2010 N=143
2011 N=161
2012 N=287
2013 N=250
2014 N=284
2015 N=169
2016 N=114
[%] resistente Stämme
Tabelle2
2006/2007 N=154
2008 N=166
2009 N=160
2010 N=143
2011 N=161
2012 N=287
2013 N=250
2014 N=284
2015 N=169
2016 N=114
log2 MHK90-Wert
Ferkel
ESBL Kalb
JahrKalbSchweinGeflügel
2006/200772.30.2
20081141.4
2009193.81.8
2010183.91.4
201125.410.63.6
2012207.92.3
201329.20.6
2014340.6
201526.75.51
201629.83.73.6
Ferkel
2006/2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
Prävalenz ESBL bildender E. coli [%]
Pute
Masthahn
E. coliFerkel
2006/2007 N=3452008 N=2402009 N=1242010 N=1562011 N=1832012 N=1502015 N=1342016 N=133
Ampicillin62676971.475.47457.562.4
Amox/Clav32211.32.21.330
Cephalothin27191928.623.719.421.1
Chloramphenicol31262724.232.822.7
Gentamicin106111310.911.32.26.8
Tetrazyklin80737778.979.272.759.762.4
Trimeth/Sulfa50506155.9595643.351.1
Summe
n=3452401241561831501341331465
2006/2007 N=3452008 N=2402009 N=1242010 N=1562011 N=1832012 N=1502015 N=1342016 N=133
Colistin40.5488880.5
Nalidixinsäure128256256128128256256128
Ciprofloxacinn.g.n.g.n.g.n.g.n.g.40.50.5
Enrofloxacin0.5110.50.5821
Cefotaxim0.120.120.120.120.120.50.120.12
Ceftiofur0.50.50.50.50.5110.5
Masthahn
2006/2007 N=345
2008 N=240
2009 N=124
2010 N=156
2011 N=183
2012 N=150
2015 N=134
2016 N=133
[%] resistente Stämme
Colistin
2006/2007 N=345
2008 N=240
2009 N=124
2010 N=156
2011 N=183
2012 N=150
2015 N=134
2016 N=133
log2 MHK90-Wert
E. coli PutePutealle Indikationen
2006/2007 N=1662006/2007 N=1662008 N=1332009 N=852010 N=952011 N=1252012 N=1592013 N=1092014 N=1102015 N=1142016 N=96
Ampicillin61.961.965.473.542.159.749.7334033.343.8
Amoxi/Clav2.42.41.55.31.151.30.91.82.63.1
Cephalothin42.842.836.833.422.1208.314.513.215.6
Chloramph14.914.921.126.621.125.818.922
Enrofloxacin334.504.21.51.35.56.46.15.2
Gentamicin1.81.82.32.311.613.68.803.72.66.3
Tetrazyklin70.270.262.452.836.84827.716.537.315.825
Trimet/Sulfa35.735.721.821.521.122.425.88.330713.5
n=166166133859512515910911011496
2006/2007 N=1662008 N=1332009 N=852010 N=952011 N=1252012 N=1592013 N=1092014 N=1102015 N=1142016 N=96
Imipenemn.g.n.g.n.g.n.g.0.250.250.250.250.250.25
Colistin0.50.580.588120.50.5
Nalidixinsäure256128128256256256128256128256
Ciprofloxacinn.g.n.g.n.g.n.g.0.250.50.50.50.50.5
Cefotaxim0.120.120.120.120.120.120.120.120.120.12
Ceftiofur0.50.50.50.50.50.50.50.50.50.5
2006/2007 N=166
2006/2007 N=166
2008 N=133
2009 N=85
2010 N=95
2011 N=125
2012 N=159
2013 N=109
2014 N=110
2015 N=114
2016 N=96
[%] resistente Stämme
2006/2007 N=166
2008 N=133
2009 N=85
2010 N=95
2011 N=125
2012 N=159
2013 N=109
2014 N=110
2015 N=114
2016 N=96
log2 MHK90-Wert
E. coliMasthahn
2006/2007 N=302008 N=212009 N=292010 N=422011 N=742012 N=352013 N=382014 N=312015 N=1092016 N=77
Ampicillin6343525035.642.935.838.73335.1
Amoxi/Clav1710311.91.411.4001.86.5
Cephalothin37242723.825.915.86.56.415.6
Chloramph10537.16.88.617.6
Enrofloxacin3539.59.65.75.39.76.42.6
Gentamicin3004.89.614.37.93.23.77.8
Tetrazyklin40242133.335.634.323.735.516.518.2
Trimet/Sulfa4314301916.414.318.425.823.916.9
n=302129427435383110977486
2006/2007 N=302008 N=212009 N=292010 N=422011 N=742012 N=352013 N=382014 N=312015 N=1092016 N=77
Ceftiofur10.50.540.5160.50.50.50.5
Cefotaxim0.50.120.1240.12160.120.120.120.25
Nalidixinsäure256256256256256256256256256128
Ciprofloxacinn.g.n.g.n.g.n.g.n.g.0.50.540.50.5
Colistin0.50.50.5111110.50.5
0.0150.030.060.120.250.51248163264
log2
-6-5-4-3-2-10123456
2006/2007 N=302008 N=212009 N=292010 N=422011 N=742012 N=352013 N=382014 N=312015 N=109
Ceftiofur0-1-12-14-1-1-1
Cefotaxim-1-3-32-34-3-3-3
Nalidixinsäure888888888
Ciprofloxacinn.g.n.g.n.g.n.g.n.g.-1-12-1
Colistin-1-1-100000-1
2006/2007 N=30
2008 N=21
2009 N=29
2010 N=42
2011 N=74
2012 N=35
2013 N=38
2014 N=31
2015 N=109
2016 N=77
[%] resistente Stämme
2006/2007 N=30
2008 N=21
2009 N=29
2010 N=42
2011 N=74
2012 N=35
2013 N=38
2014 N=31
2015 N=109
2016 N=77
log2 MHK90-Wert [mg/L]
Tab. 1.6. Anteil mcr-1 positiver Isolate an Colistin-resistenten (E. coli)
SchweinRindGeflügelOthers
2004/050%0%0%0%
2005/060%0%0%0%
2006/076%25%33%0%
20085%0%64%0%
200927%0%92%0%
201047%45%77%0%
201149%0%85%0%
201244%0%95%100%
2013*62%25%0%
2014*45%57%0%
201554%0%50%0%
Table 1.4. Anteil Colistin-resistenter Isolate am Probeneingang
SchweinRindGeflügelOthers
2004/055.1%0.7%0.5%0.0%
2005/063.5%1.1%0.4%0.0%
2006/079.7%2.2%2.7%3.6%
20085.7%4.5%3.3%4.5%
20099.4%3.4%5.5%0.0%
201012.4%2.2%4.5%0.8%
201117.8%1.5%5.3%1.7%
201215.8%0.7%5.2%0.0%
2013*4.9%1.1%0.0%
2014*2.1%2.1%1.1%
201512.3%3.4%0.5%1.0%
Table 1.5. Anteil mcr-1 positiver Isolate am Probeneingang (E. coli)
SchweinRindGeflügelOthers
2004/050.0%0.0%0.0%0.0%
2005/060.0%0.0%0.0%0.0%
2006/070.6%0.5%0.9%0.0%
20080.3%0.0%2.1%0.0%
20092.6%0.0%5.1%0.0%
20105.8%1.0%3.4%0.0%
20118.7%0.0%4.5%0.0%
20126.9%0.0%5.0%1.7%
2013*3.0%0.3%0.0%
2014*0.9%1.2%0.0%
20156.6%0.0%0.3%0.0%
Schwein
Rind
Geflügel
Schwein
Rind
Geflügel
Schwein
Rind
Geflügel
-
Seite 19 Symposium Antibiotikaresistenz in der LM-Kette, Heike Kaspar Seite 19
E. coli, Kalb, Indikation: Enteritis; 2008 - 2017
0
10
20
30
40
50
60
70
80
90
100
Ampicillin Amox/Clav Gentamicin Tetrazyklin Trimeth/Sulfa
[%] r
esis
tent
e St
ämm
e
2006/2007 N=154 2008 N=166 2009 N=160 2010 N=143 2011 N=161 2012 N=287
2013 N=250 2014 N=284 2015 N=169 2016 N=114 2017 N=114
Diagramm1
AmpicillinAmpicillinAmpicillinAmpicillinAmpicillinAmpicillinAmpicillinAmpicillinAmpicillinAmpicillinAmpicillin
Amox/ClavAmox/ClavAmox/ClavAmox/ClavAmox/ClavAmox/ClavAmox/ClavAmox/ClavAmox/ClavAmox/ClavAmox/Clav
GentamicinGentamicinGentamicinGentamicinGentamicinGentamicinGentamicinGentamicinGentamicinGentamicinGentamicin
TetrazyklinTetrazyklinTetrazyklinTetrazyklinTetrazyklinTetrazyklinTetrazyklinTetrazyklinTetrazyklinTetrazyklinTetrazyklin
Trimeth/SulfaTrimeth/SulfaTrimeth/SulfaTrimeth/SulfaTrimeth/SulfaTrimeth/SulfaTrimeth/SulfaTrimeth/SulfaTrimeth/SulfaTrimeth/SulfaTrimeth/Sulfa
2006/2007 N=154
2008 N=166
2009 N=160
2010 N=143
2011 N=161
2012 N=287
2013 N=250
2014 N=284
2015 N=169
2016 N=114
2017 N=114
[%] resistente Stämme
68
70
76.3
76.9
79.7
76.3
77.6
71.5
68.6
66.7
75.4
18
16
15
19.6
17.4
15
18.8
21.5
26
10.5
16.7
23
21
25
35
39.9
28.6
40.4
37.7
22.5
19.3
24.6
71
71
68.1
69.2
75.7
70.4
74.4
63.7
59.8
64
65.8
44
51
48.1
52.4
49.4
57.8
55.6
47.2
42.6
39.5
44.7
Kalb
E. coli Kalb
2006/2007 N=1542008 N=1662009 N=1602010 N=1432011 N=1612012 N=2872013 N=2502014 N=2842015 N=1692016 N=1142017 N=114
Ampicillin687076.376.979.776.377.671.568.666.775.4
Amox/Clav18161519.617.41518.821.52610.516.7
Gentamicin2321253539.928.640.437.722.519.324.6
Tetrazyklin717168.169.275.770.474.463.759.86465.8
Trimeth/Sulfa445148.152.449.457.855.647.242.639.544.7
Summe
n=1541661601431732872502841691141142014
2006/2007 N=1542008 N=1662009 N=1602010 N=1432011 N=1612012 N=2872013 N=2502014 N=2842015 N=1692016 N=1142017 N=114
Imipenemn.g.n.g.n.g.n.g.n.g.0.250.250.250.250.250.25
Colistin0.50.50.5121120.50.50.5
Nalidixinsäure256256256256256256256256256256256
Ciprofloxacinn.g.n.g.n.g.n.g.n.g.323232323232
Enrofloxacin3232323232323232323232
Cefotaxim116326464646464646464
Ceftiofur264128128128128128128128128128
Kalb
2006/2007 N=154
2008 N=166
2009 N=160
2010 N=143
2011 N=161
2012 N=287
2013 N=250
resistente Stämme [%]Achsentitel
ESBL
2006/2007 N=154
2008 N=166
2009 N=160
2010 N=143
2011 N=161
2012 N=287
2013 N=250
2014 N=284
2015 N=169
2016 N=114
2017 N=114
[%] resistente Stämme
Tabelle2
2006/2007 N=154
2008 N=166
2009 N=160
2010 N=143
2011 N=161
2012 N=287
2013 N=250
2014 N=284
2015 N=169
2016 N=114
2017 N=114
log2 MHK90-Wert
Ferkel
ESBL Kalb
JahrKalbSchweinGeflügel
2006/200772.30.2
20081141.4
2009193.81.8
2010183.91.4
201125.410.63.6
2012207.92.3
201329.20.6
2014340.6
201526.75.51
201629.83.73.6
Ferkel
2006/2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
Prävalenz ESBL bildender E. coli [%]
Pute
Masthahn
E. coliFerkel
2006/2007 N=3452008 N=2402009 N=1242010 N=1562011 N=1832012 N=1502015 N=1342016 N=1332017 N=118
Ampicillin62676971.475.47457.562.462.7
Amox/Clav32211.32.21.3303.4
Chloramphenicol31262724.232.822.7
Gentamicin106111310.911.32.26.87.7
Tetrazyklin80737778.979.272.759.762.455.6
Trimeth/Sulfa50506155.9595643.351.145.3
Summe
n=3452401241561831501341331181583
2006/2007 N=3452008 N=2402009 N=1242010 N=1562011 N=1832012 N=1502015 N=1342016 N=1332017 N=118
Imipenemn.g.n.g.n.g.n.g.n.g.0.250.250.250.25
Colistin40.5488880.54
Nalidixinsäure128256256128128256256128128
Ciprofloxacinn.g.n.g.n.g.n.g.n.g.40.50.50.5
Enrofloxacin0.5110.50.58211
Cefotaxim0.120.120.120.120.120.50.120.120.12
Ceftiofur0.50.50.50.50.5110.50.5
Masthahn
2006/2007 N=345
2008 N=240
2009 N=124
2010 N=156
2011 N=183
2012 N=150
2015 N=134
2016 N=133
2017 N=118
[%] resistente Stämme
Colistin
2006/2007 N=345
2008 N=240
2009 N=124
2010 N=156
2011 N=183
2012 N=150
2015 N=134
2016 N=133
2017 N=118
log2 MHK90-Wert
E. coli PutePutealle Indikationen
2006/2007 N=1662006/2007 N=1662008 N=1332009 N=852010 N=952011 N=1252012 N=1592013 N=1092014 N=1102015 N=1142016 N=962017 N=64
Ampicillin61.961.965.473.542.159.749.7334033.343.845.3
Amoxi/Clav2.42.41.55.31.151.30.91.82.63.10
Cephalothin42.842.836.833.422.1208.314.513.215.626.6
Chloramph14.914.921.126.621.125.818.922
Enrofloxacin334.504.21.51.35.56.46.15.26.3
Gentamicin1.81.82.32.311.613.68.803.72.66.39.4
Tetrazyklin70.270.262.452.836.84827.716.537.315.82523.4
Trimet/Sulfa35.735.721.821.521.122.425.88.330713.510.9
n=166166133859512515910911011496641422
2006/2007 N=1662008 N=1332009 N=852010 N=952011 N=1252012 N=1592013 N=1092014 N=1102015 N=1142016 N=962017 N=64
Imipenemn.g.n.g.n.g.n.g.0.250.250.250.250.250.250.25
Colistin0.50.580.588120.50.50.5
Nalidixinsäure256128128256256256128256128256128
Ciprofloxacinn.g.n.g.n.g.n.g.0.250.50.50.50.50.50.5
Cefotaxim0.120.120.120.120.120.120.120.120.120.120.12
Ceftiofur0.50.50.50.50.50.50.50.50.50.50.5
2006/2007 N=166
2006/2007 N=166
2008 N=133
2009 N=85
2010 N=95
2011 N=125
2012 N=159
2013 N=109
2014 N=110
2015 N=114
2016 N=96
2017 N=64
[%] resistente Stämme
2006/2007 N=166
2008 N=133
2009 N=85
2010 N=95
2011 N=125
2012 N=159
2013 N=109
2014 N=110
2015 N=114
2016 N=96
2017 N=64
log2 MHK90-Wert
E. coliMasthahn
2006/2007 N=302008 N=212009 N=292010 N=422011 N=742012 N=352013 N=382014 N=312015 N=1092016 N=772017 N=45
Ampicillin6343525035.642.935.838.73335.144.4
Amoxi/Clav1710311.91.411.4001.86.52.2
Cephalothin37242723.825.915.86.56.415.615.6
Chloramph10537.16.88.617.6
Enrofloxacin3539.59.65.75.39.76.42.62.2
Gentamicin3004.89.614.37.93.23.77.82.2
Tetrazyklin40242133.335.634.323.735.516.518.226.7
Trimet/Sulfa4314301916.414.318.425.823.916.920
n=30212942743538311097745531
2006/2007 N=302008 N=212009 N=292010 N=422011 N=742012 N=352013 N=382014 N=312015 N=1092016 N=772017 N=45
Ceftiofur10.50.540.5160.50.50.50.50.5
Cefotaxim0.50.120.1240.12160.120.120.120.250.12
Nalidixinsäure256256256256256256256256256128256
Ciprofloxacinn.g.n.g.n.g.n.g.n.g.0.50.540.50.50.5
Colistin0.50.50.5111110.50.50.5
0.0150.030.060.120.250.51248163264
log2
-6-5-4-3-2-10123456
2006/2007 N=302008 N=212009 N=292010 N=422011 N=742012 N=352013 N=382014 N=312015 N=109
Ceftiofur0-1-12-14-1-1-1
Cefotaxim-1-3-32-34-3-3-3
Nalidixinsäure888888888
Ciprofloxacinn.g.n.g.n.g.n.g.n.g.-1-12-1
Colistin-1-1-100000-1
2006/2007 N=30
2008 N=21
2009 N=29
2010 N=42
2011 N=74
2012 N=35
2013 N=38
2014 N=31
2015 N=109
2016 N=77
2017 N=45
[%] resistente Stämme
2006/2007 N=30
2008 N=21
2009 N=29
2010 N=42
2011 N=74
2012 N=35
2013 N=38
2014 N=31
2015 N=109
2016 N=77
2017 N=45
log2 MHK90-Wert
Tab. 1.6. Anteil mcr-1 positiver Isolate an Colistin-resistenten (E. coli)
SchweinRindGeflügelOthers
2004/050%0%0%0%
2005/060%0%0%0%
2006/076%25%33%0%
20085%0%64%0%
200927%0%92%0%
201047%45%77%0%
201149%0%85%0%
201244%0%95%100%
2013*62%25%0%
2014*45%57%0%
201554%0%50%0%
Table 1.4. Anteil Colistin-resistenter Isolate am Probeneingang
SchweinRindGeflügelOthers
2004/055.1%0.7%0.5%0.0%
2005/063.5%1.1%0.4%0.0%
2006/079.7%2.2%2.7%3.6%
20085.7%4.5%3.3%4.5%
20099.4%3.4%5.5%0.0%
201012.4%2.2%4.5%0.8%
201117.8%1.5%5.3%1.7%
201215.8%0.7%5.2%0.0%
2013*4.9%1.1%0.0%
2014*2.1%2.1%1.1%
201512.3%3.4%0.5%1.0%
Table 1.5. Anteil mcr-1 positiver Isolate am Probeneingang (E. coli)
SchweinRindGeflügelOthers
2004/050.0%0.0%0.0%0.0%
2005/060.0%0.0%0.0%0.0%
2006/070.6%0.5%0.9%0.0%
20080.3%0.0%2.1%0.0%
20092.6%0.0%5.1%0.0%
20105.8%1.0%3.4%0.0%
20118.7%0.0%4.5%0.0%
20126.9%0.0%5.0%1.7%
2013*3.0%0.3%0.0%
2014*0.9%1.2%0.0%
20156.6%0.0%0.3%0.0%
Schwein
Rind
Geflügel
Schwein
Rind
Geflügel
Schwein
Rind
Geflügel
-
Seite 20 Symposium Antibiotikaresistenz in der LM-Kette, Heike Kaspar
Ergebnisse E. coli, Kalb, MHK90-Daten Indikation: Enteritis; 2006 - 2017
Ciprofloxacin ab 2012 untersucht
Diagramm1
ColistinColistinColistinColistinColistinColistinColistinColistinColistinColistinColistin
NalidixinsäureNalidixinsäureNalidixinsäureNalidixinsäureNalidixinsäureNalidixinsäureNalidixinsäureNalidixinsäureNalidixinsäureNalidixinsäureNalidixinsäure
CiprofloxacinCiprofloxacinCiprofloxacinCiprofloxacinCiprofloxacinCiprofloxacinCiprofloxacinCiprofloxacinCiprofloxacinCiprofloxacinCiprofloxacin
EnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacin
CefotaximCefotaximCefotaximCefotaximCefotaximCefotaximCefotaximCefotaximCefotaximCefotaximCefotaxim
CeftiofurCeftiofurCeftiofurCeftiofurCeftiofurCeftiofurCeftiofurCeftiofurCeftiofurCeftiofurCeftiofur
2006/2007 N=154
2008 N=166
2009 N=160
2010 N=143
2011 N=161
2012 N=287
2013 N=250
2014 N=284
2015 N=169
2016 N=114
2017 N=114
log2 MHK90-Wert
0.5
0.5
0.5
1
2
1
1
2
0.5
0.5
0.5
256
256
256
256
256
256
256
256
256
256
256
0
0
0
0
0
32
32
32
32
32
32
32
32
32
32
32
32
32
32
32
32
32
1
16
32
64
64
64
64
64
64
64
64
2
64
128
128
128
128
128
128
128
128
128
Kalb
E. coli Kalb
2006/2007 N=1542008 N=1662009 N=1602010 N=1432011 N=1612012 N=2872013 N=2502014 N=2842015 N=1692016 N=1142017 N=114
Ampicillin687076.376.979.776.377.671.568.666.775.4
Amox/Clav18161519.617.41518.821.52610.516.7
Cephalothin443741.348.342.446.439.4424349.1
Chloramph495150.659.455.548.1
Gentamicin2321253539.928.640.437.722.519.324.6
Tetrazyklin717168.169.275.770.474.463.759.86465.8
Trimeth/Sulfa445148.152.449.457.855.647.242.639.544.7
Summe
n=1541661601431732872502841691141142014
2006/2007 N=1542008 N=1662009 N=1602010 N=1432011 N=1612012 N=2872013 N=2502014 N=2842015 N=1692016 N=1142017 N=114
Colistin0.50.50.5121120.50.50.5
Nalidixinsäure256256256256256256256256256256256
Ciprofloxacinn.g.n.g.n.g.n.g.n.g.323232323232
Enrofloxacin3232323232323232323232
Cefotaxim116326464646464646464
Ceftiofur264128128128128128128128128128
Kalb
2006/2007 N=154
2008 N=166
2009 N=160
2010 N=143
2011 N=161
2012 N=287
2013 N=250
resistente Stämme [%]Achsentitel
ESBL
2006/2007 N=154
2008 N=166
2009 N=160
2010 N=143
2011 N=161
2012 N=287
2013 N=250
2014 N=284
2015 N=169
2016 N=114
2017 N=114
[%] resistente Stämme
Tabelle2
2006/2007 N=154
2008 N=166
2009 N=160
2010 N=143
2011 N=161
2012 N=287
2013 N=250
2014 N=284
2015 N=169
2016 N=114
2017 N=114
log2 MHK90-Wert
Ferkel
ESBL Kalb
JahrKalbSchweinGeflügel
2006/200772.30.2
20081141.4
2009193.81.8
2010183.91.4
201125.410.63.6
2012207.92.3
201329.20.6
2014340.6
201526.75.51
201629.83.73.6
Ferkel
2006/2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
Prävalenz ESBL bildender E. coli [%]
Pute
Masthahn
E. coliFerkel
2006/2007 N=3452008 N=2402009 N=1242010 N=1562011 N=1832012 N=1502015 N=1342016 N=1332017 N=118
Ampicillin62676971.475.47457.562.462.7
Amox/Clav32211.32.21.3303.4
Chloramphenicol31262724.232.822.7
Gentamicin106111310.911.32.26.87.7
Tetrazyklin80737778.979.272.759.762.455.6
Trimeth/Sulfa50506155.9595643.351.145.3
Summe
n=3452401241561831501341331181583
2006/2007 N=3452008 N=2402009 N=1242010 N=1562011 N=1832012 N=1502015 N=1342016 N=1332017 N=118
Imipenemn.g.n.g.n.g.n.g.n.g.0.250.250.250.25
Colistin40.5488880.54
Nalidixinsäure128256256128128256256128128
Ciprofloxacinn.g.n.g.n.g.n.g.n.g.40.50.50.5
Enrofloxacin0.5110.50.58211
Cefotaxim0.120.120.120.120.120.50.120.120.12
Ceftiofur0.50.50.50.50.5110.50.5
Masthahn
2006/2007 N=345
2008 N=240
2009 N=124
2010 N=156
2011 N=183
2012 N=150
2015 N=134
2016 N=133
2017 N=118
[%] resistente Stämme
Colistin
2006/2007 N=345
2008 N=240
2009 N=124
2010 N=156
2011 N=183
2012 N=150
2015 N=134
2016 N=133
2017 N=118
log2 MHK90-Wert
E. coli PutePutealle Indikationen
2006/2007 N=1662006/2007 N=1662008 N=1332009 N=852010 N=952011 N=1252012 N=1592013 N=1092014 N=1102015 N=1142016 N=962017 N=64
Ampicillin61.961.965.473.542.159.749.7334033.343.845.3
Amoxi/Clav2.42.41.55.31.151.30.91.82.63.10
Cephalothin42.842.836.833.422.1208.314.513.215.626.6
Chloramph14.914.921.126.621.125.818.922
Enrofloxacin334.504.21.51.35.56.46.15.26.3
Gentamicin1.81.82.32.311.613.68.803.72.66.39.4
Tetrazyklin70.270.262.452.836.84827.716.537.315.82523.4
Trimet/Sulfa35.735.721.821.521.122.425.88.330713.510.9
n=166166133859512515910911011496641422
2006/2007 N=1662008 N=1332009 N=852010 N=952011 N=1252012 N=1592013 N=1092014 N=1102015 N=1142016 N=962017 N=64
Imipenemn.g.n.g.n.g.n.g.0.250.250.250.250.250.250.25
Colistin0.50.580.588120.50.50.5
Nalidixinsäure256128128256256256128256128256128
Ciprofloxacinn.g.n.g.n.g.n.g.0.250.50.50.50.50.50.5
Cefotaxim0.120.120.120.120.120.120.120.120.120.120.12
Ceftiofur0.50.50.50.50.50.50.50.50.50.50.5
2006/2007 N=166
2006/2007 N=166
2008 N=133
2009 N=85
2010 N=95
2011 N=125
2012 N=159
2013 N=109
2014 N=110
2015 N=114
2016 N=96
2017 N=64
[%] resistente Stämme
2006/2007 N=166
2008 N=133
2009 N=85
2010 N=95
2011 N=125
2012 N=159
2013 N=109
2014 N=110
2015 N=114
2016 N=96
2017 N=64
log2 MHK90-Wert
E. coliMasthahn
2006/2007 N=302008 N=212009 N=292010 N=422011 N=742012 N=352013 N=382014 N=312015 N=1092016 N=772017 N=45
Ampicillin6343525035.642.935.838.73335.144.4
Amoxi/Clav1710311.91.411.4001.86.52.2
Cephalothin37242723.825.915.86.56.415.615.6
Chloramph10537.16.88.617.6
Enrofloxacin3539.59.65.75.39.76.42.62.2
Gentamicin3004.89.614.37.93.23.77.82.2
Tetrazyklin40242133.335.634.323.735.516.518.226.7
Trimet/Sulfa4314301916.414.318.425.823.916.920
n=30212942743538311097745531
2006/2007 N=302008 N=212009 N=292010 N=422011 N=742012 N=352013 N=382014 N=312015 N=1092016 N=772017 N=45
Ceftiofur10.50.540.5160.50.50.50.50.5
Cefotaxim0.50.120.1240.12160.120.120.120.250.12
Nalidixinsäure256256256256256256256256256128256
Ciprofloxacinn.g.n.g.n.g.n.g.n.g.0.50.540.50.50.5
Colistin0.50.50.5111110.50.50.5
0.0150.030.060.120.250.51248163264
log2
-6-5-4-3-2-10123456
2006/2007 N=302008 N=212009 N=292010 N=422011 N=742012 N=352013 N=382014 N=312015 N=109
Ceftiofur0-1-12-14-1-1-1
Cefotaxim-1-3-32-34-3-3-3
Nalidixinsäure888888888
Ciprofloxacinn.g.n.g.n.g.n.g.n.g.-1-12-1
Colistin-1-1-100000-1
2006/2007 N=30
2008 N=21
2009 N=29
2010 N=42
2011 N=74
2012 N=35
2013 N=38
2014 N=31
2015 N=109
2016 N=77
2017 N=45
[%] resistente Stämme
2006/2007 N=30
2008 N=21
2009 N=29
2010 N=42
2011 N=74
2012 N=35
2013 N=38
2014 N=31
2015 N=109
2016 N=77
2017 N=45
log2 MHK90-Wert
Tab. 1.6. Anteil mcr-1 positiver Isolate an Colistin-resistenten (E. coli)
SchweinRindGeflügelOthers
2004/050%0%0%0%
2005/060%0%0%0%
2006/076%25%33%0%
20085%0%64%0%
200927%0%92%0%
201047%45%77%0%
201149%0%85%0%
201244%0%95%100%
2013*62%25%0%
2014*45%57%0%
201554%0%50%0%
Table 1.4. Anteil Colistin-resistenter Isolate am Probeneingang
SchweinRindGeflügelOthers
2004/055.1%0.7%0.5%0.0%
2005/063.5%1.1%0.4%0.0%
2006/079.7%2.2%2.7%3.6%
20085.7%4.5%3.3%4.5%
20099.4%3.4%5.5%0.0%
201012.4%2.2%4.5%0.8%
201117.8%1.5%5.3%1.7%
201215.8%0.7%5.2%0.0%
2013*4.9%1.1%0.0%
2014*2.1%2.1%1.1%
201512.3%3.4%0.5%1.0%
Table 1.5. Anteil mcr-1 positiver Isolate am Probeneingang (E. coli)
SchweinRindGeflügelOthers
2004/050.0%0.0%0.0%0.0%
2005/060.0%0.0%0.0%0.0%
2006/070.6%0.5%0.9%0.0%
20080.3%0.0%2.1%0.0%
20092.6%0.0%5.1%0.0%
20105.8%1.0%3.4%0.0%
20118.7%0.0%4.5%0.0%
20126.9%0.0%5.0%1.7%
2013*3.0%0.3%0.0%
2014*0.9%1.2%0.0%
20156.6%0.0%0.3%0.0%
Schwein
Rind
Geflügel
Schwein
Rind
Geflügel
Schwein
Rind
Geflügel
-
Seite 21 Symposium Antibiotikaresistenz in der LM-Kette, Heike Kaspar Seite 21
E. coli, Prävalenzdaten ESBL-bildender (%)
Ergebnisse
Diagramm1
2006/20072006/20072006/20072006/2007
2008200820082008
2009200920092009
2010201020102010
2011201120112011
2012201220122012
2013201320132013
2014201420142014
2015201520152015
2016201620162016
Schwein (2013 und 2014 nicht untersucht)
Kalb
Geflügel
Hund
Prävalenz ESBL E. coli [%]
2.3
7
0.2
0
4
11
1.4
0
3.8
19
1.8
5.4
3.9
18
1.4
3.2
10.6
25.4
3.6
4.7
7.9
20
2.3
1.4
29
0.6
7.8
34
0.6
14.7
5.5
26.7
1
4.4
3.7
29.8
3.6
3.8
Tabelle1
Schwein (2013 und 2014 nicht untersucht)KalbGeflügelHund
2006/20072.370.20
20084111.40
20093.8191.85.4
20103.9181.43.2
201110.625.43.64.7
20127.9202.31.4
2013290.67.8
2014340.614.7
20155.526.714.4
20163.729.83.63.8
Tabelle1
Schwein (2013 und 2014 nicht untersucht)
Kalb
Geflügel
Hund
Prävalenz ESBL E. coli [%]
-
Seite 22 Symposium Antibiotikaresistenz in der LM-Kette, Heike Kaspar Seite 22
Ergebnisse des Nationalen Resistenzmonitoring
Mastitis
-
Seite 23 Symposium Antibiotikaresistenz in der LM-Kette, Heike Kaspar
E. coli, Milchrind, Indikation: Mastitis; 2002 - 2016
Ergebnisse
Diagramm1
AmpicillinAmpicillinAmpicillinAmpicillinAmpicillinAmpicillinAmpicillin
Amoxicillin/ClavulansäureAmoxicillin/ClavulansäureAmoxicillin/ClavulansäureAmoxicillin/ClavulansäureAmoxicillin/ClavulansäureAmoxicillin/ClavulansäureAmoxicillin/Clavulansäure
CeftiofurCeftiofurCeftiofurCeftiofurCeftiofurCeftiofurCeftiofur
GentamicinGentamicinGentamicinGentamicinGentamicinGentamicinGentamicin
TetracyclinTetracyclinTetracyclinTetracyclinTetracyclinTetracyclinTetracyclin
Trimethoprim/SulfamethoxazolTrimethoprim/SulfamethoxazolTrimethoprim/SulfamethoxazolTrimethoprim/SulfamethoxazolTrimethoprim/SulfamethoxazolTrimethoprim/SulfamethoxazolTrimethoprim/Sulfamethoxazol
2002/2003 N=258
2004/2005 N=353
2005/2006 N=534
2010 N=305
2012 N=323
2014 N=240
2016 N=275
resistente Isolate [%]
14
15
13.3
13.1
17
18.7
17.8
0
0
0.9
2.6
2.5
4.1
3.3
0
1.4
1.1
3
8.7
6.6
7.6
2.3
2.5
1.1
2
1.5
5
2.9
11.2
14.5
11.2
11.5
10.5
16.6
16
12
7.5
6.9
5.2
7.4
12.4
12.4
Kalb
2008 N=1662009 N=1602010 N=1432011 N=1612012 N=2872013 N=2502014 N=2842015 N=169
Ampicillin7076.376.979.776.377.671.568.6
Amoxicillin/Clavulansäure161519.617.41518.821.526
CEF3741.348.342.446.439.442
Gentamicin21253539.928.640.437.722.5
Tetrayclin7168.169.275.770.474.463.759.8
Trimethoprim/Sulfamethoxazol5148.152.449.457.855.647.242.6
n=166160143173287250284169
Kalb
ESBL [%]
2006/20077
200811
200919
201018
201125.4
201220
201329.2
201434
201526
201629.8
Kalb
2008 N=166
2010 N=143
2012 N=287
2014 N=284
2015 N=169
resistente Stämme [%]
Milchrind Mastitis
ESBL [%]
Prävalenz ESBL E. coli Kalb [%]
Schwein
Mastitis E. coli 2016
2002/2003 N=2582004/2005 N=3532005/2006 N=5342010 N=3052012 N=3232014 N=2402016 N=275
Ampicillin141513.313.11718.717.8
Amoxicillin/Clavulansäure000.92.62.54.13.3
Ceftiofur01.41.138.76.67.6
Gentamicin2.32.51.121.552.9
Tetracyclin11.214.511.211.510.516.616
Trimethoprim/Sulfamethoxazol127.56.95.27.412.412.4
n258353534305323241275
nach CLSI VET01S 3 rd. Ed
Schwein
2002/2003 N=258
2004/2005 N=353
2005/2006 N=534
2010 N=305
2012 N=323
2014 N=240
2016 N=275
resistente Isolate [%]
Schwein 2
E.coli Ferkel Enteritis
2005/2006 N=3322006/2007 N=3452008 N=2402009 N=1242010 N=1602011 N=1832012 N=1502015 N=1342016 N=133
Ampicillin5962676971.474.97457.562.4
Amoxicillin/Clavulansäure132211.32.11.330
Cephalothin2227191928.623.719.421.1
CHL2731262724.2
Gentamicin6106111310.711.32.26.8
Tetracyclin7880737778.979.172.759.762.4
Trimethoprim/Sulfamethoxazol5250506155.958.35643.351.1
n=332345240124160183150134133
Schwein
ESBL [%]
2006/20072.3
20084
20093.8
20103.9
201110.6
20127.9
20155.5
20163.7
Schwein 2
2005/2006 N=332
2008 N=240
2010 N=160
2012 N=150
2015 N=134
2016 N=133
resistente Stämme [%]
Legehenne
ESBL [%]
Prävalenz ESBL E. coli Schwein [%]
masthahn
E. coliFerkel
2005/20062006/2007200820092010201120122015
AMP5962676971.4
AUG132211.3
CEP2227191928.6
CHL2731262724.2
GEN61061113
TET7880737778.9
SXT5250506155.9
n=332345240124160
E. coliFerkel
2006/2007200820092010
AMP62676971.4
AUG32211.3
CEP27191928.6
CHL31262724.2
GEN1061113
TET80737778.9
SXT50506155.9
n=345240124160
E. coliFerkel
2006/2007 N=3452008 N=2402009 N=1242010 N=1602011 N=116
AMP62676971.470.7
AMC32211.310.7
CEF27191928.631.8
CHL31262724.233.3
GEN106111312
TET80737778.978.6
SXT50506155.957.3
n=345240124160116
masthahn
00000
% resistente Stämme
Pute
0000
% resistente Stämme
Kleintier GIT
00000
% resistant strains
Kleintier UTI
2006/2007 N=1592008 N=1762009 N=722010 N=1032011 N=1622012 N=1962013 N=1952014 N=1762015 N=1662016 N=132
Ampicillin19321721.723.814.414.916.515.720.5
Amoxicillin/Clavulansäure1000.9500.5000
Cephalothin161587.516.74.1464.5
CHL4665.851
Enrofloxacin32014.31.53.61.134.5
Gentamicin6201.93.13.11.50.62.40.8
Tetracyclin27311515.521.714.913.81714.521.2
Trimethoprim/Sulfamethoxazol91537.86.83.63.69.14.83.8
n=15917672103162196195176166132
Kleintier UTI
2006/2007 N=159
2008 N=176
2010 N=103
2012 N=196
2014 N=176
2015 N=166
2016 N=132
resistente Stämme [%]
Hund UTI
2006/2007 N=302008 N=212009 N=292010 N=422011 N=742012 N=352013 N=382014 N=312015 N=1092016 N=77
Ampicillin6343525035.642.935.838.73335.1
Amoxicillin/Clavulansäure1710311.91.411.4001.86.5
Cephalothin37242723.825.915.86.56.415.6
CHL10537.16.88.617.6
Enrofloxacin3539.59.65.75.39.76.42.6
Gentamicin3004.89.614.37.93.23.77.8
Tetracyclin40242133.335.634.323.735.516.518.2
Trimethoprim/Sulfamethoxazol4314301916.414.318.425.823.916.9
n=302129427435383110977
Geflügel
ESBL [%]
2006/20070.2
20081.4
20091.8
20101.4
20113.6
20122.3
20130.6
20140.6N=321
20151N=400
20163.6N=305
2010 N=422011 N=742012 N=352013 N=382014 N=31
AMP5035.642.935.838.7
AMC11.91.411.400
CEF23.825.915.86.5
CHL7.16.88.617.6
ENR9.59.65.75.39.7
GEN4.89.614.37.93.2
TET33.335.634.323.735.5
SXT1916.414.318.425.8
n=4274353831
Hund UTI
2006/2007 N=30
2008 N=21
2010 N=42
2012 N=35
2014 N=31
2015 N=109
2016 N=77
resistente Stämme [%]
Hund GIT
ESBL [%]
Prävalenz ESBL-bildende E. coli Geflügel [%]
Katze GIT
2010 N=42
2011 N=74
2012 N=35
2013 N=38
2014 N=31
resistnat strains [%]
Katze UTI
E. coliPutealle Indikationen
2006/2007 N=1662008 N=1332009 N=852010 N=952011 N=1252012 N=1592013 N=1092014 N=1102015 N=1142016 N=96
Ampicillin61.965.473.542.159.749.7334033.343.8
Amoxicillin/Clavulansäure2.41.55.31.151.30.91.82.63.1
Cephalothin42.836.833.422.1208.314.513.215.6
CHL14.921.126.621.125.818.922
Enrofloxacin34.504.21.51.35.56.46.15.2
Gentamicin1.82.32.311.613.68.803.72.66.3
Tetracyclin70.262.452.836.84827.716.537.315.825
Trimethoprim/Sulfamethoxazol35.721.821.521.122.425.88.330713.5
n=166133859512515910911011496
E. coliPuteSeptikämie
2006/2007 N=1242008 N=982009 N=662010 N=742011 N=632012 N=1292013 N=882014 N=1002015 N=982016 N=78
AMP60666439.263.149.630.73935.747.4
AMC2201.41.50.8023.13.8
CEF43402923256.81414.319.2
CHL13242720.319.717.120.5
ENR2404.11.51.64.577.16.4
GEN12510.812.37023.17.7
TET69645935.143.124.8173516.329.5
SXT36241725.323.125.69.1308.215.4
n=12498667463129881009878
E. coliPuteResp. Symptomatik
2006/200720082009201020112012 N=282013 N=212014 N=11
AMP6355845051.453.642.945.5
AUG7011003.64.80
CEP401837202014.318.2
CHL2092621.122.928.627.3
ENR3905.35.709.50
GEN05015.811.417.909.1
TET70504747.44039.314.363.6
SXT37142626.317.128.64.830
n=3022192035282111
E. coliPuteSeptikämie
2010 N=742011 N=632012 N=1292013 N=882014 N=100
AMP39.263.149.630.739
AMC1.41.50.802
CEF23256.814
CHL20.319.717.120.5
ENR4.11.51.64.57
GEN10.812.3702
TET35.143.124.81735
SXT25.323.125.69.130
n=746312988100
Katze UTI
2006/2007 N=166
2008 N=133
2010 N=95
2012 N=159
2014 N=110
2015 N=114
2016 N=96
resistente Stämme [%]
2006/2007 N=124
2008 N=98
2009 N=66
2010 N=74
2011 N=63
2012 N=129
2013 N=88
2014 N=100
2015 N=98
2016 N=78
resistente Stämme [%]
2006/2007
2008
2009
2010
2011
2012 N=28
2013 N=21
2014 N=11
resistente Stämme [%]
2010 N=74
2011 N=63
2012 N=129
2013 N=88
2014 N=100
resistant strains [%]
E. coliKleintierGIT
2006/2007 N=962008 N=382009 N=252010 N=272011 N=182012 N=182013 N=172014 N=652015 N=472016 N=13
AMP21.926.32018.544.435.338.531.9
AMC2347.4011.107.72.1
CHL1580190
GEN Hund006.604.8011.12.68
GEN Katze04.800012.504.5
TET15292411.128.644.423.521.525.5
SXT1313203.71927.823.521.521.3
n=9638252718181747
Hund 5417151710109258
Katze 42211010888225
alle E. coli
Hund
ESBL [%]
2006/20070
20080
20095.4
20103.2
20114.7
20121.4
20137
201414.7
20154.4
20163.8
2006/2007 N=96
2008 N=38
2009 N=25
2010 N=27
2014 N=65
2015 N=47
resistente Stämme {%]
ESBL [%]
Prävalenz ESBL E. coli Hund [%]
E. coliKleintierUGT
2006/2007 N=632008 N=292009 N=132010 N=242011 N=322012 N=332013 N=372014 N=322015 N=452016 N=59
Ampicillin2735.738.921.731.333.337.828.133.337.3*nicht sensibel (>8)
Amoxicillin/Clavulansäure15.921.428.606.2512.210.818.717.813.6*nicht sensibel (>8)
CEF191126.712.512.516.216.9
CHL5704.218.824.6
Gentamicin/Hund00904.313.601913.34.5
Gentamicin/Katze0004.200006.76.7
Enrofloxacin/Hund21113621.48.722.719.216.116.720.5
Marbofloxacin/Hund*11.122.716.216.116.720.5
Tetracyclin21329.112.521.927.335.112.931.123.7
Trimethoprim/Sulfamethoxazol161844.420.818.818.224.316.12022
n=63291324323337324559
Hund 4319112322263044
Katze 2092911111515
2006/2007 N=63
2008 N=29
2009 N=13
2010 N=24
2014 N=32
2015 N=45
2016 N=59
resistente Stämme [%]
E. coliUGT
2008 N=192010 N=132012 N=332014 N=192015 N=55
AMP31.615.433.336.836.4
AMC15.8012.126.316.4
ENR10.57.721.216.712.7
GEN009.11910.9
MAR21.2012.7
TET26.37.727.31127.3
SXT15.823.118.216.723.6
n=1913331955
alle E. coli
Hund
ESBL [%]
2006/20070
20080
20095.4
20103.2
20114.7
20121.4
20137
2008 N=19
2010 N=13
2012 N=33
2014 N=19
2015 N=55
resistente Stämme {%]
2006/2007
2008
2009
2010
2011
2012
2013
ESBL [%]
Prävalenz ESBL E. coli Hund [%]
0
0
5.4
3.2
4.7
1.4
7
E. coliGIT
2008 N=172010 N=172013 N=92014 N=382015 N=25
AMP35.511.833.347.432
AMC05.907.94
GEN0011.12.68
TET47.15.922.221.116
SXT0022.226.316
n=22.227181817
alle E. coli
Hund
ESBL [%]
2006/20070
20080
20095.4
20103.2
20114.7
20121.4
20137
2008 N=17
2010 N=17
2013 N=9
2014 N=38
2015 N=25
resistente Stämme {%]
2006/2007
2008
2009
2010
2011
2012
2013
ESBL [%]
Prävalenz ESBL E. coli Hund [%]
0
0
5.4
3.2
4.7
1.4
7
-
Seite 24 Symposium Antibiotikaresistenz in der LM-Kette, Heike Kaspar
Wirkstoffe, für die keine klinischen Grenzwerte vorhanden sind
Studienjahr
MHK90 [mg/L] 2004/ 2005
2005/ 2006 2010 2012 2014 2016
Cefotaxim - 0,12 0,12 8 0,12 0,5
Cefquinom 0,12 0,06 0,12 8 0,12 0,5
Colistin 0,25 0,5 1 1 2 0,5
Doxycyclin 16 8 8 8 16 16
Enrofloxacin 0,06 0,06 0,06 0,06 0,06 0,06
Nalidixinsäure 4 4 4 4 4 8
N = 353 534 305 323 241 275
E. coli, Milchrind, Indikation: Mastitis, MHK90-Daten; 2002 - 2016
Ergebnisse
-
Seite 25 Symposium Antibiotikaresistenz in der LM-Kette, Heike Kaspar
S. aureus, Milchrind, Indikation: Mastitis; 2008 - 2015
Ergebnisse
-
Seite 26 Symposium Antibiotikaresistenz in der LM-Kette, Heike Kaspar
Ergebnisse
S. aureus, Milchrind, Indikation: Mastitis, MHK90-Daten; 2008 - 2015
MHK90 [mg/L] Studienjahr
Wirkstoffe, für die keine klinischen Grenzwerte vorhanden sind
2008 2009 2011 2013 2015
Cefoperazon 2 2 2 2 4
Cefotaxim 2 2 2 4 4
Cefquinom 1 1 1 1 1
Clindamycin 0,12 0,25 0,25 0,25 0,25
Enrofloxacin 0,25 0,25 0,25 0,25 0,5
N = 394 210 346 205 363
-
Seite 27 Symposium Antibiotikaresistenz in der LM-Kette, Heike Kaspar
Ergebnisse des Nationalen Resistenzmonitoring
Geflügel
-
Seite 28 Symposium Antibiotikaresistenz in der LM-Kette, Heike Kaspar
E. coli, Pute, verschiedene Indikationen; 2006 - 2017
Ergebnisse
Diagramm1
AmpicillinAmpicillinAmpicillinAmpicillinAmpicillinAmpicillinAmpicillinAmpicillinAmpicillinAmpicillinAmpicillinAmpicillin
Amoxi/ClavAmoxi/ClavAmoxi/ClavAmoxi/ClavAmoxi/ClavAmoxi/ClavAmoxi/ClavAmoxi/ClavAmoxi/ClavAmoxi/ClavAmoxi/ClavAmoxi/Clav
ChloramphChloramphChloramphChloramphChloramphChloramphChloramphChloramphChloramphChloramphChloramphChloramph
EnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacin
GentamicinGentamicinGentamicinGentamicinGentamicinGentamicinGentamicinGentamicinGentamicinGentamicinGentamicinGentamicin
TetrazyklinTetrazyklinTetrazyklinTetrazyklinTetrazyklinTetrazyklinTetrazyklinTetrazyklinTetrazyklinTetrazyklinTetrazyklinTetrazyklin
Trimet/SulfaTrimet/SulfaTrimet/SulfaTrimet/SulfaTrimet/SulfaTrimet/SulfaTrimet/SulfaTrimet/SulfaTrimet/SulfaTrimet/SulfaTrimet/SulfaTrimet/Sulfa
2006/2007 N=166
2006/2007 N=166
2008 N=133
2009 N=85
2010 N=95
2011 N=125
2012 N=159
2013 N=109
2014 N=110
2015 N=114
2016 N=96
2017 N=64
[%] resistente Stämme
61.9
65.4
73.5
42.1
59.7
49.7
33
40
33.3
43.8
45.3
2.4
1.5
5.3
1.1
5
1.3
0.9
1.8
2.6
3.1
0
14.9
21.1
26.6
21.1
25.8
18.9
22
3
4.5
0
4.2
1.5
1.3
5.5
6.4
6.1
5.2
6.3
1.8
2.3
2.3
11.6
13.6
8.8
0
3.7
2.6
6.3
9.4
70.2
62.4
52.8
36.8
48
27.7
16.5
37.3
15.8
25
23.4
35.7
21.8
21.5
21.1
22.4
25.8
8.3
30
7
13.5
10.9
Kalb
E. coli Kalb
2006/2007 N=1542008 N=1662009 N=1602010 N=1432011 N=1612012 N=2872013 N=2502014 N=2842015 N=1692016 N=1142017 N=114
Ampicillin687076.376.979.776.377.671.568.666.775.4
Amox/Clav18161519.617.41518.821.52610.516.7
Cephalothin443741.348.342.446.439.4424349.1
Chloramph495150.659.455.548.1
Gentamicin2321253539.928.640.437.722.519.324.6
Tetrazyklin717168.169.275.770.474.463.759.86465.8
Trimeth/Sulfa445148.152.449.457.855.647.242.639.544.7
Summe
n=1541661601431732872502841691141142014
2006/2007 N=1542008 N=1662009 N=1602010 N=1432011 N=1612012 N=2872013 N=2502014 N=2842015 N=1692016 N=1142017 N=114
Imipenemn.g.n.g.n.g.n.g.n.g.0.250.250.250.250.250.25
Colistin0.50.50.5121120.50.50.5
Nalidixinsäure256256256256256256256256256256256
Ciprofloxacinn.g.n.g.n.g.n.g.n.g.323232323232
Enrofloxacin3232323232323232323232
Cefotaxim116326464646464646464
Ceftiofur264128128128128128128128128128
Kalb
2006/2007 N=154
2008 N=166
2009 N=160
2010 N=143
2011 N=161
2012 N=287
2013 N=250
resistente Stämme [%]Achsentitel
ESBL
2006/2007 N=154
2008 N=166
2009 N=160
2010 N=143
2011 N=161
2012 N=287
2013 N=250
2014 N=284
2015 N=169
2016 N=114
2017 N=114
[%] resistente Stämme
Tabelle2
2006/2007 N=154
2008 N=166
2009 N=160
2010 N=143
2011 N=161
2012 N=287
2013 N=250
2014 N=284
2015 N=169
2016 N=114
2017 N=114
log2 MHK90-Wert
Ferkel
ESBL Kalb
JahrKalbSchweinGeflügel
2006/200772.30.2
20081141.4
2009193.81.8
2010183.91.4
201125.410.63.6
2012207.92.3
201329.20.6
2014340.6
201526.75.51
201629.83.73.6
Ferkel
2006/2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
Prävalenz ESBL bildender E. coli [%]
Pute
Masthahn
E. coliFerkel
2006/2007 N=3452008 N=2402009 N=1242010 N=1562011 N=1832012 N=1502015 N=1342016 N=1332017 N=118
Ampicillin62676971.475.47457.562.462.7
Amox/Clav32211.32.21.3303.4
Cephalothin27191928.623.719.421.119.5
Chloramphenicol31262724.232.822.7
Gentamicin106111310.911.32.26.87.7
Tetrazyklin80737778.979.272.759.762.455.6
Trimeth/Sulfa50506155.9595643.351.145.3
Summe
n=3452401241561831501341331181583
2006/2007 N=3452008 N=2402009 N=1242010 N=1562011 N=1832012 N=1502015 N=1342016 N=1332017 N=118
Imipenemn.g.n.g.n.g.n.g.n.g.0.250.250.250.25
Colistin40.5488880.54
Nalidixinsäure128256256128128256256128128
Ciprofloxacinn.g.n.g.n.g.n.g.n.g.40.50.50.5
Enrofloxacin0.5110.50.58211
Cefotaxim0.120.120.120.120.120.50.120.120.12
Ceftiofur0.50.50.50.50.5110.50.5
Masthahn
2006/2007 N=345
2008 N=240
2009 N=124
2010 N=156
2011 N=183
2012 N=150
2015 N=134
2016 N=133
2017 N=118
[%] resistente Stämme
Colistin
2006/2007 N=345
2008 N=240
2009 N=124
2010 N=156
2011 N=183
2012 N=150
2015 N=134
2016 N=133
2017 N=118
log2 MHK90-Wert
E. coli PutePutealle Indikationen
2006/2007 N=1662006/2007 N=1662008 N=1332009 N=852010 N=952011 N=1252012 N=1592013 N=1092014 N=1102015 N=1142016 N=962017 N=64
Ampicillin61.961.965.473.542.159.749.7334033.343.845.3
Amoxi/Clav2.42.41.55.31.151.30.91.82.63.10
Chloramph14.914.921.126.621.125.818.922
Enrofloxacin334.504.21.51.35.56.46.15.26.3
Gentamicin1.81.82.32.311.613.68.803.72.66.39.4
Tetrazyklin70.270.262.452.836.84827.716.537.315.82523.4
Trimet/Sulfa35.735.721.821.521.122.425.88.330713.510.9
n=166166133859512515910911011496641422
2006/2007 N=1662008 N=1332009 N=852010 N=952011 N=1252012 N=1592013 N=1092014 N=1102015 N=1142016 N=962017 N=64
Imipenemn.g.n.g.n.g.n.g.0.250.250.250.250.250.250.25
Colistin0.50.580.588120.50.50.5
Nalidixinsäure256128128256256256128256128256128
Ciprofloxacinn.g.n.g.n.g.n.g.0.250.50.50.50.50.50.5
Cefotaxim0.120.120.120.120.120.120.120.120.120.120.12
Ceftiofur0.50.50.50.50.50.50.50.50.50.50.5
2006/2007 N=166
2006/2007 N=166
2008 N=133
2009 N=85
2010 N=95
2011 N=125
2012 N=159
2013 N=109
2014 N=110
2015 N=114
2016 N=96
2017 N=64
[%] resistente Stämme
2006/2007 N=166
2008 N=133
2009 N=85
2010 N=95
2011 N=125
2012 N=159
2013 N=109
2014 N=110
2015 N=114
2016 N=96
2017 N=64
log2 MHK90-Wert
E. coliMasthahn
2006/2007 N=302008 N=212009 N=292010 N=422011 N=742012 N=352013 N=382014 N=312015 N=1092016 N=772017 N=45
Ampicillin6343525035.642.935.838.73335.144.4
Amoxi/Clav1710311.91.411.4001.86.52.2
Cephalothin37242723.825.915.86.56.415.615.6
Chloramph10537.16.88.617.6
Enrofloxacin3539.59.65.75.39.76.42.62.2
Gentamicin3004.89.614.37.93.23.77.82.2
Tetrazyklin40242133.335.634.323.735.516.518.226.7
Trimet/Sulfa4314301916.414.318.425.823.916.920
n=30212942743538311097745531
2006/2007 N=302008 N=212009 N=292010 N=422011 N=742012 N=352013 N=382014 N=312015 N=1092016 N=772017 N=45
Ceftiofur10.50.540.5160.50.50.50.50.5
Cefotaxim0.50.120.1240.12160.120.120.120.250.12
Nalidixinsäure256256256256256256256256256128256
Ciprofloxacinn.g.n.g.n.g.n.g.n.g.0.50.540.50.50.5
Colistin0.50.50.5111110.50.50.5
0.0150.030.060.120.250.51248163264
log2
-6-5-4-3-2-10123456
2006/2007 N=302008 N=212009 N=292010 N=422011 N=742012 N=352013 N=382014 N=312015 N=109
Ceftiofur0-1-12-14-1-1-1
Cefotaxim-1-3-32-34-3-3-3
Nalidixinsäure888888888
Ciprofloxacinn.g.n.g.n.g.n.g.n.g.-1-12-1
Colistin-1-1-100000-1
2006/2007 N=30
2008 N=21
2009 N=29
2010 N=42
2011 N=74
2012 N=35
2013 N=38
2014 N=31
2015 N=109
2016 N=77
2017 N=45
[%] resistente Stämme
2006/2007 N=30
2008 N=21
2009 N=29
2010 N=42
2011 N=74
2012 N=35
2013 N=38
2014 N=31
2015 N=109
2016 N=77
2017 N=45
log2 MHK90-Wert
Tab. 1.6. Anteil mcr-1 positiver Isolate an Colistin-resistenten (E. coli)
SchweinRindGeflügelOthers
2004/050%0%0%0%
2005/060%0%0%0%
2006/076%25%33%0%
20085%0%64%0%
200927%0%92%0%
201047%45%77%0%
201149%0%85%0%
201244%0%95%100%
2013*62%25%0%
2014*45%57%0%
201554%0%50%0%
Table 1.4. Anteil Colistin-resistenter Isolate am Probeneingang
SchweinRindGeflügelOthers
2004/055.1%0.7%0.5%0.0%
2005/063.5%1.1%0.4%0.0%
2006/079.7%2.2%2.7%3.6%
20085.7%4.5%3.3%4.5%
20099.4%3.4%5.5%0.0%
201012.4%2.2%4.5%0.8%
201117.8%1.5%5.3%1.7%
201215.8%0.7%5.2%0.0%
2013*4.9%1.1%0.0%
2014*2.1%2.1%1.1%
201512.3%3.4%0.5%1.0%
Table 1.5. Anteil mcr-1 positiver Isolate am Probeneingang (E. coli)
SchweinRindGeflügelOthers
2004/050.0%0.0%0.0%0.0%
2005/060.0%0.0%0.0%0.0%
2006/070.6%0.5%0.9%0.0%
20080.3%0.0%2.1%0.0%
20092.6%0.0%5.1%0.0%
20105.8%1.0%3.4%0.0%
20118.7%0.0%4.5%0.0%
20126.9%0.0%5.0%1.7%
2013*3.0%0.3%0.0%
2014*0.9%1.2%0.0%
20156.6%0.0%0.3%0.0%
Schwein
Rind
Geflügel
Schwein
Rind
Geflügel
Schwein
Rind
Geflügel
-
Seite 29 Symposium Antibiotikaresistenz in der LM-Kette, Heike Kaspar
Ergebnisse
E. coli, Pute, MHK90-Daten, verschiedene Indikationen; 2006 - 2017
0,0625
0,125
0,25
0,5
1
2
4
8
16
32
64
128
256
Imipenem Colistin Nalidixinsäure Ciprofloxacin Cefotaxim Ceftiofur
log2
MHK
90-W
ert
2006/2007 N=166 2008 N=133 2009 N=85 2010 N=95
2011 N=125 2012 N=159 2013 N=109 2014 N=110
2015 N=114 2016 N=96 2017 N=64
Ciprofloxacin ab 2012 untersucht
-
Seite 30
E. coli, Broiler, verschiedene Indikationen; 2006 - 2017
Ergebnisse
Symposium Antibiotikaresistenz in der LM-Kette, Heike Kaspar
Diagramm1
AmpicillinAmpicillinAmpicillinAmpicillinAmpicillinAmpicillinAmpicillinAmpicillinAmpicillinAmpicillinAmpicillin
Amoxi/ClavAmoxi/ClavAmoxi/ClavAmoxi/ClavAmoxi/ClavAmoxi/ClavAmoxi/ClavAmoxi/ClavAmoxi/ClavAmoxi/ClavAmoxi/Clav
ChloramphChloramphChloramphChloramphChloramphChloramphChloramphChloramphChloramphChloramphChloramph
EnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacin
GentamicinGentamicinGentamicinGentamicinGentamicinGentamicinGentamicinGentamicinGentamicinGentamicinGentamicin
TetrazyklinTetrazyklinTetrazyklinTetrazyklinTetrazyklinTetrazyklinTetrazyklinTetrazyklinTetrazyklinTetrazyklinTetrazyklin
Trimet/SulfaTrimet/SulfaTrimet/SulfaTrimet/SulfaTrimet/SulfaTrimet/SulfaTrimet/SulfaTrimet/SulfaTrimet/SulfaTrimet/SulfaTrimet/Sulfa
2006/2007 N=30
2008 N=21
2009 N=29
2010 N=42
2011 N=74
2012 N=35
2013 N=38
2014 N=31
2015 N=109
2016 N=77
2017 N=45
[%] resistente Stämme
63
43
52
50
35.6
42.9
35.8
38.7
33
35.1
44.4
17
10
3
11.9
1.4
11.4
0
0
1.8
6.5
2.2
10
5
3
7.1
6.8
8.6
17.6
3
5
3
9.5
9.6
5.7
5.3
9.7
6.4
2.6
2.2
3
0
0
4.8
9.6
14.3
7.9
3.2
3.7
7.8
2.2
40
24
21
33.3
35.6
34.3
23.7
35.5
16.5
18.2
26.7
43
14
30
19
16.4
14.3
18.4
25.8
23.9
16.9
20
Kalb
E. coli Kalb
2006/2007 N=1542008 N=1662009 N=1602010 N=1432011 N=1612012 N=2872013 N=2502014 N=2842015 N=1692016 N=1142017 N=114
Ampicillin687076.376.979.776.377.671.568.666.775.4
Amox/Clav18161519.617.41518.821.52610.516.7
Cephalothin443741.348.342.446.439.4424349.1
Chloramph495150.659.455.548.1
Gentamicin2321253539.928.640.437.722.519.324.6
Tetrazyklin717168.169.275.770.474.463.759.86465.8
Trimeth/Sulfa445148.152.449.457.855.647.242.639.544.7
Summe
n=1541661601431732872502841691141142014
2006/2007 N=1542008 N=1662009 N=1602010 N=1432011 N=1612012 N=2872013 N=2502014 N=2842015 N=1692016 N=1142017 N=114
Imipenemn.g.n.g.n.g.n.g.n.g.0.250.250.250.250.250.25
Colistin0.50.50.5121120.50.50.5
Nalidixinsäure256256256256256256256256256256256
Ciprofloxacinn.g.n.g.n.g.n.g.n.g.323232323232
Enrofloxacin3232323232323232323232
Cefotaxim116326464646464646464
Ceftiofur264128128128128128128128128128
Kalb
2006/2007 N=154
2008 N=166
2009 N=160
2010 N=143
2011 N=161
2012 N=287
2013 N=250
resistente Stämme [%]Achsentitel
ESBL
2006/2007 N=154
2008 N=166
2009 N=160
2010 N=143
2011 N=161
2012 N=287
2013 N=250
2014 N=284
2015 N=169
2016 N=114
2017 N=114
[%] resistente Stämme
Tabelle2
2006/2007 N=154
2008 N=166
2009 N=160
2010 N=143
2011 N=161
2012 N=287
2013 N=250
2014 N=284
2015 N=169
2016 N=114
2017 N=114
log2 MHK90-Wert
Ferkel
ESBL Kalb
JahrKalbSchweinGeflügel
2006/200772.30.2
20081141.4
2009193.81.8
2010183.91.4
201125.410.63.6
2012207.92.3
201329.20.6
2014340.6
201526.75.51
201629.83.73.6
Ferkel
2006/2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
Prävalenz ESBL bildender E. coli [%]
Pute
Masthahn
E. coliFerkel
2006/2007 N=3452008 N=2402009 N=1242010 N=1562011 N=1832012 N=1502015 N=1342016 N=1332017 N=118
Ampicillin62676971.475.47457.562.462.7
Amox/Clav32211.32.21.3303.4
Cephalothin27191928.623.719.421.119.5
Chloramphenicol31262724.232.822.7
Gentamicin106111310.911.32.26.87.7
Tetrazyklin80737778.979.272.759.762.455.6
Trimeth/Sulfa50506155.9595643.351.145.3
Summe
n=3452401241561831501341331181583
2006/2007 N=3452008 N=2402009 N=1242010 N=1562011 N=1832012 N=1502015 N=1342016 N=1332017 N=118
Imipenemn.g.n.g.n.g.n.g.n.g.0.250.250.250.25
Colistin40.5488880.54
Nalidixinsäure128256256128128256256128128
Ciprofloxacinn.g.n.g.n.g.n.g.n.g.40.50.50.5
Enrofloxacin0.5110.50.58211
Cefotaxim0.120.120.120.120.120.50.120.120.12
Ceftiofur0.50.50.50.50.5110.50.5
Masthahn
2006/2007 N=345
2008 N=240
2009 N=124
2010 N=156
2011 N=183
2012 N=150
2015 N=134
2016 N=133
2017 N=118
[%] resistente Stämme
Colistin
2006/2007 N=345
2008 N=240
2009 N=124
2010 N=156
2011 N=183
2012 N=150
2015 N=134
2016 N=133
2017 N=118
log2 MHK90-Wert
E. coli PutePutealle Indikationen
2006/2007 N=1662006/2007 N=1662008 N=1332009 N=852010 N=952011 N=1252012 N=1592013 N=1092014 N=1102015 N=1142016 N=962017 N=64
Ampicillin61.961.965.473.542.159.749.7334033.343.845.3
Amoxi/Clav2.42.41.55.31.151.30.91.82.63.10
Cephalothin42.842.836.833.422.1208.314.513.215.626.6
Chloramph14.914.921.126.621.125.818.922
Enrofloxacin334.504.21.51.35.56.46.15.26.3
Gentamicin1.81.82.32.311.613.68.803.72.66.39.4
Tetrazyklin70.270.262.452.836.84827.716.537.315.82523.4
Trimet/Sulfa35.735.721.821.521.122.425.88.330713.510.9
n=166166133859512515910911011496641422
2006/2007 N=1662008 N=1332009 N=852010 N=952011 N=1252012 N=1592013 N=1092014 N=1102015 N=1142016 N=962017 N=64
Imipenemn.g.n.g.n.g.n.g.0.250.250.250.250.250.250.25
Colistin0.50.580.588120.50.50.5
Nalidixinsäure256128128256256256128256128256128
Ciprofloxacinn.g.n.g.n.g.n.g.0.250.50.50.50.50.50.5
Cefotaxim0.120.120.120.120.120.120.120.120.120.120.12
Ceftiofur0.50.50.50.50.50.50.50.50.50.50.5
2006/2007 N=166
2006/2007 N=166
2008 N=133
2009 N=85
2010 N=95
2011 N=125
2012 N=159
2013 N=109
2014 N=110
2015 N=114
2016 N=96
2017 N=64
[%] resistente Stämme
2006/2007 N=166
2008 N=133
2009 N=85
2010 N=95
2011 N=125
2012 N=159
2013 N=109
2014 N=110
2015 N=114
2016 N=96
2017 N=64
log2 MHK90-Wert
E. coliMasthahn
2006/2007 N=302008 N=212009 N=292010 N=422011 N=742012 N=352013 N=382014 N=312015 N=1092016 N=772017 N=45
Ampicillin6343525035.642.935.838.73335.144.4
Amoxi/Clav1710311.91.411.4001.86.52.2
Chloramph10537.16.88.617.6
Enrofloxacin3539.59.65.75.39.76.42.62.2
Gentamicin3004.89.614.37.93.23.77.82.2
Tetrazyklin40242133.335.634.323.735.516.518.226.7
Trimet/Sulfa4314301916.414.318.425.823.916.920
n=30212942743538311097745531
2006/2007 N=302008 N=212009 N=292010 N=422011 N=742012 N=352013 N=382014 N=312015 N=1092016 N=772017 N=45
Ceftiofur10.50.540.5160.50.50.50.50.5
Cefotaxim0.50.120.1240.12160.120.120.120.250.12
Nalidixinsäure256256256256256256256256256128256
Ciprofloxacinn.g.n.g.n.g.n.g.n.g.0.50.540.50.50.5
Colistin0.50.50.5111110.50.50.5
0.0150.030.060.120.250.51248163264
log2
-6-5-4-3-2-10123456
2006/2007 N=302008 N=212009 N=292010 N=422011 N=742012 N=352013 N=382014 N=312015 N=109
Ceftiofur0-1-12-14-1-1-1
Cefotaxim-1-3-32-34-3-3-3
Nalidixinsäure888888888
Ciprofloxacinn.g.n.g.n.g.n.g.n.g.-1-12-1
Colistin-1-1-100000-1
2006/2007 N=30
2008 N=21
2009 N=29
2010 N=42
2011 N=74
2012 N=35
2013 N=38
2014 N=31
2015 N=109
2016 N=77
2017 N=45
[%] resistente Stämme
2006/2007 N=30
2008 N=21
2009 N=29
2010 N=42
2011 N=74
2012 N=35
2013 N=38
2014 N=31
2015 N=109
2016 N=77
2017 N=45
log2 MHK90-Wert
Tab. 1.6. Anteil mcr-1 positiver Isolate an Colistin-resistenten (E. coli)
SchweinRindGeflügelOthers
2004/050%0%0%0%
2005/060%0%0%0%
2006/076%25%33%0%
20085%0%64%0%
200927%0%92%0%
201047%45%77%0%
201149%0%85%0%
201244%0%95%100%
2013*62%25%0%
2014*45%57%0%
201554%0%50%0%
Table 1.4. Anteil Colistin-resistenter Isolate am Probeneingang
SchweinRindGeflügelOthers
2004/055.1%0.7%0.5%0.0%
2005/063.5%1.1%0.4%0.0%
2006/079.7%2.2%2.7%3.6%
20085.7%4.5%3.3%4.5%
20099.4%3.4%5.5%0.0%
201012.4%2.2%4.5%0.8%
201117.8%1.5%5.3%1.7%
201215.8%0.7%5.2%0.0%
2013*4.9%1.1%0.0%
2014*2.1%2.1%1.1%
201512.3%3.4%0.5%1.0%
Table 1.5. Anteil mcr-1 positiver Isolate am Probeneingang (E. coli)
SchweinRindGeflügelOthers
2004/050.0%0.0%0.0%0.0%
2005/060.0%0.0%0.0%0.0%
2006/070.6%0.5%0.9%0.0%
20080.3%0.0%2.1%0.0%
20092.6%0.0%5.1%0.0%
20105.8%1.0%3.4%0.0%
20118.7%0.0%4.5%0.0%
20126.9%0.0%5.0%1.7%
2013*3.0%0.3%0.0%
2014*0.9%1.2%0.0%
20156.6%0.0%0.3%0.0%
Schwein
Rind
Geflügel
Schwein
Rind
Geflügel
Schwein
Rind
Geflügel
-
Seite 31
E. coli, Broiler, MHK90-Daten, verschiedene Indikationen; 2006 - 2017
Ergebnisse
Symposium Antibiotikaresistenz in der LM-Kette, Heike Kaspar
Diagramm1
CeftiofurCeftiofurCeftiofurCeftiofurCeftiofurCeftiofurCeftiofurCeftiofurCeftiofurCeftiofurCeftiofur
CefotaximCefotaximCefotaximCefotaximCefotaximCefotaximCefotaximCefotaximCefotaximCefotaximCefotaxim
NalidixinsäureNalidixinsäureNalidixinsäureNalidixinsäureNalidixinsäureNalidixinsäureNalidixinsäureNalidixinsäureNalidixinsäureNalidixinsäureNalidixinsäure
CiprofloxacinCiprofloxacinCiprofloxacinCiprofloxacinCiprofloxacinCiprofloxacinCiprofloxacinCiprofloxacinCiprofloxacinCiprofloxacinCiprofloxacin
ColistinColistinColistinColistinColistinColistinColistinColistinColistinColistinColistin
2006/2007 N=30
2008 N=21
2009 N=29
2010 N=42
2011 N=74
2012 N=35
2013 N=38
2014 N=31
2015 N=109
2016 N=77
2017 N=45
log2 MHK90-Wert
1
0.5
0.5
4
0.5
16
0.5
0.5
0.5
0.5
0.5
0.5
0.12
0.12
4
0.12
16
0.12
0.12
0.12
0.25
0.12
256
256
256
256
256
256
256
256
256
128
256
0
0
0
0
0
0.5
0.5
4
0.5
0.5
0.5
0.5
0.5
0.5
1
1
1
1
1
0.5
0.5
0.5
Kalb
E. coli Kalb
2006/2007 N=1542008 N=1662009 N=1602010 N=1432011 N=1612012 N=2872013 N=2502014 N=2842015 N=1692016 N=1142017 N=114
Ampicillin687076.376.979.776.377.671.568.666.775.4
Amox/Clav18161519.617.41518.821.52610.516.7
Cephalothin443741.348.342.446.439.4424349.1
Chloramph495150.659.455.548.1
Gentamicin2321253539.928.640.437.722.519.324.6
Tetrazyklin717168.169.275.770.474.463.759.86465.8
Trimeth/Sulfa445148.152.449.457.855.647.242.639.544.7
Summe
n=1541661601431732872502841691141142014
2006/2007 N=1542008 N=1662009 N=1602010 N=1432011 N=1612012 N=2872013 N=2502014 N=2842015 N=1692016 N=1142017 N=114
Imipenemn.g.n.g.n.g.n.g.n.g.0.250.250.250.250.250.25
Colistin0.50.50.5121120.50.50.5
Nalidixinsäure256256256256256256256256256256256
Ciprofloxacinn.g.n.g.n.g.n.g.n.g.323232323232
Enrofloxacin3232323232323232323232
Cefotaxim116326464646464646464
Ceftiofur264128128128128128128128128128
Kalb
2006/2007 N=154
2008 N=166
2009 N=160
2010 N=143
2011 N=161
2012 N=287
2013 N=250
resistente Stämme [%]Achsentitel
ESBL
2006/2007 N=154
2008 N=166
2009 N=160
2010 N=143
2011 N=161
2012 N=287
2013 N=250
2014 N=284
2015 N=169
2016 N=114
2017 N=114
[%] resistente Stämme
Tabelle2
2006/2007 N=154
2008 N=166
2009 N=160
2010 N=143
2011 N=161
2012 N=287
2013 N=250
2014 N=284
2015 N=169
2016 N=114
2017 N=114
log2 MHK90-Wert
Ferkel
ESBL Kalb
JahrKalbSchweinGeflügel
2006/200772.30.2
20081141.4
2009193.81.8
2010183.91.4
201125.410.63.6
2012207.92.3
201329.20.6
2014340.6
201526.75.51
201629.83.73.6
Ferkel
2006/2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
Prävalenz ESBL bildender E. coli [%]
Pute
Masthahn
E. coliFerkel
2006/2007 N=3452008 N=2402009 N=1242010 N=1562011 N=1832012 N=1502015 N=1342016 N=1332017 N=118
Ampicillin62676971.475.47457.562.462.7
Amox/Clav32211.32.21.3303.4
Cephalothin27191928.623.719.421.119.5
Chloramphenicol31262724.232.822.7
Gentamicin106111310.911.32.26.87.7
Tetrazyklin80737778.979.272.759.762.455.6
Trimeth/Sulfa50506155.9595643.351.145.3
Summe
n=3452401241561831501341331181583
2006/2007 N=3452008 N=2402009 N=1242010 N=1562011 N=1832012 N=1502015 N=1342016 N=1332017 N=118
Imipenemn.g.n.g.n.g.n.g.n.g.0.250.250.250.25
Colistin40.5488880.54
Nalidixinsäure128256256128128256256128128
Ciprofloxacinn.g.n.g.n.g.n.g.n.g.40.50.50.5
Enrofloxacin0.5110.50.58211
Cefotaxim0.120.120.120.120.120.50.120.120.12
Ceftiofur0.50.50.50.50.5110.50.5
Masthahn
2006/2007 N=345
2008 N=240
2009 N=124
2010 N=156
2011 N=183
2012 N=150
2015 N=134
2016 N=133
2017 N=118
[%] resistente Stämme
Colistin
2006/2007 N=345
2008 N=240
2009 N=124